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Abstract
We analyze risk factors correlated with the initial transmission growth rate of the recent COVID-19
pandemic in different countries. The number of cases follows in its early stages an almost exponential
expansion; we chose as a starting point in each country the first day di with 30 cases and we fitted for
12 days, capturing thus the early exponential growth. We looked then for linear correlations of the
exponents α with other variables, for a sample of 126 countries. We find a positive correlation, i.e.
faster spread of COVID-19, with high confidence level with the following variables, with respective
p-value: low Temperature (4·10−7), high ratio of old vs. working-age people (3·10−6), life expectancy
(8 · 10−6), number of international tourists (1 · 10−5), earlier epidemic starting date di (2 · 10−5),
high level of physical contact in greeting habits (6 · 10−5), lung cancer prevalence (6 · 10−5), obesity
in males (1 · 10−4), share of population in urban areas (2 · 10−4), cancer prevalence (3 · 10−4),
alcohol consumption (0.0019), daily smoking prevalence (0.0036), UV index (0.004, smaller sample,
73 countries), low Vitamin D serum levels (p-value 0.002 − 0.006, smaller sample, ∼ 50 countries).
There is highly significant correlation also with blood type: positive correlation with types RH-
(2 ·10−5) and A+ (2 ·10−3), negative correlation with B+ (2 ·10−4). We also find positive correlation
with moderate confidence level (p-value of 0.02 ∼ 0.03) with: CO2/SO emissions, type-1 diabetes
in children, low vaccination coverage for Tuberculosis (BCG). Several of the above variables are
correlated with each other and so they are likely to have common interpretations. Other variables
are found to have a counterintuitive negative correlation, which may be explained due their strong
negative correlation with life expectancy: slower spread of COVID-19 is correlated with high death-
rate due to pollution, prevalence of anemia and hepatitis B, high blood pressure in females. We also
analyzed the possible existence of a bias: countries with low GDP-per capita, typically located in
warm regions, might have less intense testing and we discuss correlation with the above variables.
I. INTRODUCTION
The recent coronavirus (COVID-19) pandemic is now spreading essentially everywhere in our
planet. The growth rate of the contagion has however a very high variability among different coun-
tries, even in its very early stages, when government intervention is still almost negligible. Any factor
contributing to a faster or slower spread needs to be identified and understood with the highest de-
gree of scrutiny. In [1] the early growth rate of the contagion has been found to be correlated at high
significance with temperature T. In this work we extend a similar analysis to many other variables.
This correlational study could help further investigation in order to find causal factors and it can
help policy makers in their decisions.
Some factors are intuitive and have been found in other studies, such as temperature [1, 3–9] (see
also [10] for a different conclusion) and air travel [2, 10]; we aim here at being more exhaustive and
at finding also factors which are not “obvious” and have a potential biological origin, or correlation
with one.
The paper is organized as follows. In section II we explain our methods, in section III we show our
main results, in section IV we show the detailed results for each individual variable of our analysis,
in section V we discuss correlations among variables and in section VI we draw our conclusions.
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2II. METHOD
As in [1], we use the empirical observation that the number of COVID-19 positive cases follows a
common pattern in the majority of countries: once the number of confirmed cases reaches order 10
there is a very rapid growth, which is typically well approximated for a few weeks by an exponential.
Subsequently the exponential growth typically gradually slows down, probably due to other effects,
such as: lockdown policies from governments, a higher degree of awareness in the population or the
tracking and isolation of the positive cases. The growth is then typically stopped and reaches a peak
in countries with a strong lockdown/tracking policy.
Our aim is to find which factors correlate with the speed of contagion, in its first stage of free
propagation. For this purpose we analyzed a datasets of 126 countries taken from [12] on April 15th.
We have chosen our sample using the following rules:
• We start analyzing data from the first day di in which the number of cases in a given country
reaches a reference number Ni, which we choose to be Ni = 30 [54];
• We include only countries with at least 12 days of data, after this starting point;
• We excluded countries with too small total population (less than 300 thousands inhabitants).
We then fit the data for each country with a simple exponential curve N(t) = N0 eαt, with 2
parameters, N0 and α; here t is in units of days. In the fit we used Poissonian errors, given by
√
N ,
on the daily counting of cases.
Note that the statistical errors on the exponents α, considering Poissonian errors on the daily
counting of cases, are typically only a few percent of the spread of the values of α among the various
countries. For this reason we disregarded statistical errors on α. The analysis was done using the
software Mathematica, from Wolfram Research, Inc..
III. MAIN RESULTS
We first look for correlations with several individual variables. Most variables are taken from [13],
while for a few of them have been collected from other sources, as commented below.
1. Non-significant variables
We find no significant correlation of the COVID-19 transmission in our set of countries with many
variables, including the following ones:
1. Number of inhabitants;
2. Asthma-prevalence;
3. Participation time in leisure, social and associative life per day;
4. Population density;
5. Average precipitation per year;
6. Vaccinations coverage for: Polio, Diphteria, Tetanus, Pertussis, Hepatitis B;
7. Share of men with high-blood-pressure;
8. Diabetes prevalence (type 1 and 2, together);
9. Air pollution (“Suspended particulate matter (SPM), in micrograms per cubic metre”).
32. Significant variables, strong evidence
We find strong evidence for correlation with:
1. Temperature (negative correlation, p-value 4.4 · 10−7);
2. Old-age dependency ratio: ratio of the number of people older than 64 relative to the number
of people in the working-age (15-64 years) (positive correlation, p-value 3.3 · 10−6);
3. Life expectancy (positive correlation p-value 8.1 · 10−6);
4. International tourism: number of arrivals (positive correlation p-value 9.6 · 10−6);
5. Starting day di of the epidemic (negative correlation, p-value 1.7 · 10−5);
6. Amount of contact in greeting habits (positive correlation, p-value 5.0 · 10−5);
7. Lung cancer death rates (positive correlation, p-value 6.3 · 10−5);
8. Obesity in males (positive correlation, p-value 1.2 · 10−4);
9. Share of population in urban areas (positive correlation, p-value 1.7 · 10−4);
10. Share of population with cancer (positive correlation, p-value 2.8 · 10−4);
11. Alcohol consumption (positive correlation, p-value 0.0019);
12. Daily smoking prevalence (positive correlation, p-value 0.0036);
13. UV index (negative correlation, p-value 0.004; smaller sample, 73 countries);
14. Vitamin D serum levels (negative correlation, annual values p-value 0.006, seasonal values
0.002; smaller sample, ∼ 50 countries).
3. Significant variables, moderate evidence
We find moderate evidence for correlation with:
1. CO2 (and SO) emissions (positive correlation, p-value 0.015);
2. Type-1 diabetes in children (positive correlation, p-value 0.023);
3. Vaccination coverage for Tuberculosis (BCG) (negative correlation, p-value 0.028).
4. Significant variables, counterintuitive
Counterintuitively we also find correlations in a direction opposite to a naive expectation:
1. Death-rate-from-air-pollution (negative correlation, p-value 3.5 · 10−5);
2. Prevalence of anemia, adults and children, (negative correlation, p-value 1.4·10−4 and 7.×10−6,
respectively);
3. Share of women with high-blood-pressure (negative correlation, p-value 1.6 · 10−4);
4. Incidence of Hepatitis B (negative correlation, p-value 2.4 · 10−4);
5. PM2.5 air pollution (negative correlation, p-value 0.029).
4A. Bias due to GDP: lack of testing?
We also find a correlation with GDP per capita, which we should be an indicator of lack of
testing capabilities. Note however that GDP per capita is also quite highly correlated with another
important variable, life expectancy, as we will show in section V: high GDP per capita is related to
an older population, which is correlated with faster contagion.
Note also that correlation of contagion with GDP disappears when excluding very poor countries,
approximately below 5 thousand $ GDP per capita: this is likely due to the fact that only below a
given threshold the capability of testing becomes insufficient.
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Figure 1: Exponent α for each country vs. GDP per capita. We show the data points and the best-fit for
the linear interpolation.
Estimate Standard Error t-Statistic p-value
1 0.155 0.0111 14. 6.79× 10−27
GDP 1.28× 10−6 3.81× 10−7 3.37 0.001
R2 0.087
N 121
Table I: In the left panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters of
the linear interpolation, for correlation of α with GDP per capita (GDP). In the right panel: R2 for the
best-estimate and number of countries N .
We performed 2-variables fits, including GDP and each of the above significant variables, in order
to check if they remain still significant. In section IV we will show the results of such fits, and also
the result of individual one variable fits excluding countries below the threshold of 5 thousand $
GDP per capita. We list here below the variables that are still significant even when fitting together
with GDP.
1. Significant variables, strong evidence
In a 2-variable fit, including GDP per capita, we find strong evidence for correlation with:
1. Amount of contact in greeting habits (positive correlation, p-value 1.5 · 10−5);
2. Temperature (negative correlation, p-value 2.3 · 10−5);
3. International tourism: number of arrivals (positive correlation, p-value 2.6 · 10−4);
4. Old-age dependency ratio: ratio of the number of people older than 64 relative to the number
of people in the working-age (15-64 years) (positive correlation, p-value 5.5 · 10−4);
55. Vitamin D serum levels (negative correlation, annual values p-value 0.0032, seasonal values
0.0024; smaller sample, ∼ 50 countries).
6. Starting day of the epidemic (negative correlation, p-value 0.0037);
7. Lung cancer death rates (positive correlation, p-value 0.0039);
8. Life expectancy (positive correlation, p-value 0.0048);
2. Significant variables, moderate evidence
We find moderate evidence for:
1. UV index (negative correlation, p-value 0.01; smaller sample, 73 countries);
2. Type-I diabetes in children, 0-19 years-old (negative correlation, p-value 0.01);
3. Vaccination coverage for Tuberculosis (BCG) (negative correlation, p-value 0.023);
4. Obesity in males (positive correlation, p-value 0.02);
5. CO2 emissions (positive correlation, p-value 0.02);
6. Alcohol consumption (positive correlation, p-value 0.03);
7. Daily smoking prevalence (positive correlation, p-value 0.03);
8. Share of population in urban areas (positive correlation, p-value 0.04);
3. Significant variables, counterintuitive
Counterintuitively we still find correlations with:
1. Death rate from air pollution (negative correlation, p-value 0.002);
2. Prevalence of anemia, adults and children, (negative correlation, p-value 0.023 and 0.005);
3. Incidence of Hepatitis B (negative correlation, p-value 0.01);
4. Share of women with high-blood-pressure (negative correlation, p-value 0.03).
In the next section we analyze in more detail the significant variables, one by one (except for those
which are not significant anymore after taking into account of GDP per capita). In section V we will
analyze cross-correlations among such variables and this will also give a plausible interpretation for
the existence of the “counterintuitive” variables.
IV. RESULTS FOR EACH VARIABLE
1. Temperature
The average temperature T has been collected for the relevant period of time, ranging from January
to mid April, weighted among the main cities of a given country, see [1] for details. Results are shown
in fig. 2 and Table II.
We also found that another variable, the absolute value of latitude, has a similar amount of
correlation as for the case of T. However the two variables have a very high correlation (about 0.91)
and we do not show results for latitude here. Another variable which is also very highly correlated
is UV index and it is shown later.
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Figure 2: Exponent α for each country vs. average temperature T, for the relevant period of time, as defined
in [1]. We show the data points and the best-fit for the linear interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.239 0.0124 19.2 4.64× 10−39
T -0.00359 0.000676 -5.32 4.73× 10−7 7.1× 10−5
R2 0.186
N 126
Estimate Standard Error t-Statistic p-value
1 0.223 0.0188 11.9 7.45× 10−22
GDP 5.62× 10−7 3.93× 10−7 1.43 0.155
T -0.0033 0.000761 -4.33 0.0000311
R2 0.212
N 121
Cross-correlation 0.425
Table II: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters
of the linear interpolation, for correlation of α with temperature T. We also show the p-value, excluding
countries below 5 thousand $ GDP per capita. In the left bottom panel: same quantities for correlation of
α with temperature T and GDP per capita. In the right panels: R2 for the best-estimate and number of
countries N . We also show the correlation coefficient between the 2 variables in the two-variable fit.
2. Old-age dependency ratio
This is the ratio of the number of people older than 64 relative to the number of people in the
working-age (15-64 years). Data are shown as the proportion of dependents per 100 working-age
population, for the year 2017. Results are shown in fig. 3 and Table III. This is an interesting
finding, since it suggests that old people are not only subject to higher mortality, but also more
likely to be contagious. This could be either because they are more likely to become sick, or because
their state of sickness is longer and more contagious, or because many of them live together in nursing
homes, or all such reasons together.
Note that a similar variable is life expectancy (which we analyze later); other variables are also
highly correlated, such as median age and child dependency ratio, which we do not show here. In
analogy to the previous interpretation, data indicate that a younger population, including countries
with high percentage of children, is more immune to COVID-19, or less contagious.
710 20 30 40
0.0
0.1
0.2
0.3
0.4
Old-age dependency ratio
Ex
po
ne
nt
α(firs
t1
2
da
ys
)
Figure 3: Exponent α for each country vs. old-age dependency ratio, as defined in the text. We show the
data points and the best-fit for the linear interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.132 0.0126 10.5 9.03× 10−19
OLD 0.00326 0.000669 4.87 3.37× 10−6 0.0025
R2 0.164
N 123
Estimate Standard Error t-Statistic p-value
1 0.126 0.0132 9.56 2.42× 10−16
GDP 7.18× 10−7 4.04× 10−7 1.78 0.0778
OLD 0.0027 0.00076 3.55 0.000557
R2 0.188
N 120
Cross-correlation -0.4561
Table III: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters
of the linear interpolation, for correlation of α with old-age dependency ratio, OLD. We also show the p-
value, excluding countries below 5 thousand $ GDP per capita. In the left bottom panel: same quantities for
correlation of α with OLD and GDP per capita. In the right panels: R2 for the best-estimate and number
of countries N . We also show the correlation coefficient between the 2 variables in the two-variable fit.
3. Life expectancy
This dataset is for year 2016. It has high correlation with old-age dependency ratio. It also has
high correlations with other datasets in [13] that we do not show here, such as median age and child
dependency ratio (the ratio between under-19-year-olds and 20-to-69-year-olds). Results are shown
in fig. 4 and Table IV.
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Figure 4: Exponent α for each country vs. life expectancy. We show the data points and the best-fit for the
linear interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 -0.147 0.0716 -2.05 0.0424
LIFE 0.00446 0.00096 4.65 8.56× 10−6 0.0041
R2 0.151
N 125
Estimate Standard Error t-Statistic p-value
1 -0.11 0.0929 -1.19 0.237
LIFE 0.00386 0.00134 2.87 0.00485
GDP 3.99× 10−7 4.98× 10−7 0.801 0.424
R2 0.160
N 120
Cross-correlation -0.679
Table IV: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters of
the linear interpolation, for correlation of α with life expectancy, LIFE. We also show the p-value, excluding
countries below 5 thousand $ GDP per capita. In the left bottom panel: same quantities for correlation of
α with LIFE and GDP per capita. In the right panels: R2 for the best-estimate and number of countries N .
We also show the correlation coefficient between the 2 variables in the two-variable fit.
4. International tourism: number of arrivals
The dataset is for year 2016. Results are shown in fig. 5 and Table V. As expected, more tourists
correlate with higher speed of contagion. This is in agreement with [2, 10], that found air travel to
be an important factor, which will appear here as the number of tourists as well as a correlation
with GDP.
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Figure 5: Exponent α for each country vs. number of tourist arrivals. We show the data points and the
best-fit for the linear interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.168 0.00846 19.9 7.38× 10−38
ARR 2.13× 10−9 4.55× 10−10 4.69 8.12× 10−6 0.0002
R2 0.169
N 110
Estimate Standard Error t-Statistic p-value
1 0.146 0.0116 12.6 1.48× 10−22
GDP 1.11× 10−6 4.02× 10−7 2.76 0.00691
ARR 1.77× 10−9 4.68× 10−10 3.78 0.000265
R2 0.226
N 107
Cross-correlation -0.288
Table V: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters of
the linear interpolation, for correlation of α with number of tourist arrivals, ARR. We also show the p-value,
excluding countries below 5 thousand $ GDP per capita. In the left bottom panel: same quantities for
correlation of α with ARR and GDP per capita. In the right panels: R2 for the best-estimate and number
of countries N . We also show the correlation coefficient between the 2 variables in the two-variable fit.
5. Starting date of the epidemic
This refers to the day di chosen as a starting point, counted from December 31st 2019. Results are
shown in fig. 6 and Table VI, which shows that earlier contagion is correlated with faster contagion.
One possible interpretation is that countries which are affected later are already more aware of the
pandemic and therefore have a larger amount of social distancing, which makes the growth rate
smaller. Another possible interpretation is that there is some other underlying factor that protects
against contagion, and therefore epidemics spreads both later and slower.
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Figure 6: Exponent α for each country vs. starting date of the analysis of the epidemic, DATE, defined as
the day when the positive cases reached N = 30. Days are counted from Dec 31st 2019. We show the data
points and the best-fit for the linear interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.369 0.0421 8.76 1.21× 10−14
DATE -0.00253 0.000565 -4.48 0.0000168 0.011
R2 0.139
N 126
Estimate Standard Error t-Statistic p-value
1 0.32 0.0568 5.64 1.18× 10−7
GDP 5.85× 10−7 4.38× 10−7 1.33 0.185
DATE -0.00204 0.000689 -2.96 0.00367
R2 0.151
N 121
Cross-correlation 0.539
Table VI: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters
of the linear interpolation, for correlation of α with vs. starting date of the analysis of the epidemic, DATE,
as defined in the text. We also show the p-value, excluding countries below 5 thousand $ GDP per capita.
In the left bottom panel: same quantities for correlation of α with DATE and GDP per capita. In the
right panels: R2 for the best-estimate and number of countries N . We also show the correlation coefficient
between the 2 variables in the two-variable fit.
6. Greeting habits
A relevant variable is the level of contact in greeting habits in each country. We have subdivided
the countries in groups according to the physical contact in greeting habits; information has been
taken from [28].
1. No or little physical contact, bowing. In this group we have: Bangladesh, Cambodia, Japan,
Korea South, Sri Lanka, Thailand.
2. Handshaking between man-man and woman-woman. No or little contact man-woman. In this
group we have: India, Indonesia, Niger, Senegal, Singapore, Togo, Vietnam, Zambia
3. Handshaking. In this group we have: Australia, Austria, Bulgaria, Burkina Faso, Canada,
China, Estonia, Finland, Germany, Ghana, Madagascar, Malaysia, Mali, Malta, New Zealand,
Norway, Philippines, Rwanda, Sweden, Taiwan, Uganda, Kingdom United, States United.
4. Handshaking, plus kissing among friends and relatives, but only man-man and woman-woman.
No or little contact man-woman. In this group we have: Afghanistan, Azerbaijan, Bahrain,
Belarus, Brunei, Egypt, Guinea, Jordan, Kuwait, Kyrgyzstan, Oman, Pakistan, Qatar, Arabia
Saudi, Arab Emirates United, Uzbekistan.
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Figure 7: Exponent α for each country vs. level of contact in greeting habits, GRE, as defined in the text.
We show the data points and the best-fit for the linear interpolation.
5. Handshaking, plus kissing among friends and relatives. In this group we have: Albania, Algeria,
Argentina, Armenia, Belgium, Bolivia, and Bosnia Herzegovina, Cameroon, Chile, Colombia,
Costa Rica, Côte d’Ivoire, Croatia, Cuba, Cyprus, Czech Republic, Denmark, Dominican Re-
public, Ecuador, El Salvador, France, Georgia, Greece, Guatemala, Honduras, Hungary, Iran,
Iraq, Ireland, Israel, Italy, Jamaica, Kazakhstan, Kenya, Kosovo, Latvia, Lebanon, Lithuania,
Luxembourg, Macedonia, Mauritius, Mexico, Moldova, Montenegro, Morocco, Netherlands,
Panama, Paraguay, Peru, Poland, Portugal, Puerto Rico, Romania, Russia, Serbia, Slovakia,
Slovenia, Africa South, Switzerland, Trinidad and Tobago, Tunisia, Turkey, Ukraine, Uruguay,
Venezuela.
6. Handshaking and kissing. In this group we have: Andorra, Brazil, Spain.
We have arbitrarily assigned a variable, named GRE, from 0 to 1 to each group, namely GRE
= 0, 0.25, 0.5, 0.4, 0.8 and 1, respectively. We have chosen a ratio of 2 between group 2 and 3 and
between group 4 and 5, based on the fact that the only difference is that about half of the possible
interactions (men-women) are without contact. Results are shown in Fig. 7 and Table VII.
Note also that an outlier is visible in the plot, which corresponds to South Korea. The early
outbreak of the disease in this particular case was strongly affected by the Shincheonji Church,
which included mass prayer and worship sessions. By excluding South Korea from the dataset one
finds an even larger significance, p-value= 6.4 · 10−8 and R2 ≈ 0.23.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.111 0.019 5.8 5.47× 10−8
GRE 0.12 0.0287 4.2 0.000051 0.0029
R2 0.129
N 121
Estimate Standard Error t-Statistic p-value
1 0.079 0.0204 3.87 0.000184
GDP 1.26× 10−6 3.65× 10−7 3.45 0.000794
GRE 0.128 0.0282 4.53 0.0000149
R2 0.22
N 116
Cross-correlation 0.00560
Table VII: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters
of the linear interpolation, for correlation of α with level of contact in greeting habits, GRE, as defined in the
text. We also show the p-value, excluding countries below 5 thousand $ GDP per capita. In the left bottom
panel: same quantities for correlation of α with GRE and GDP per capita. In the right panels: R2 for the
best-estimate and number of countries N . We also show the correlation coefficient between the 2 variables
in the two-variable fit.
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7. Lung cancer death rates
This dataset refers to year 2002. Results are shown in Fig. 8 and Table VIII. Such results are
interesting and could be interpreted a priori in two ways. A first interpretation is that COVID-19
contagion might correlate to lung cancer, simply due to the fact that lung cancer is more prevalent
in countries with more old people. Such a simplistic interpretation is somehow contradicted by the
case of generic cancer death rates, discussed in section III, which is indeed less significant than lung
cancer. A better interpretation is therefore that lung cancer may be a specific risk factor for COVID-
19 contagion. This is supported also by the observation of high rates of lung cancer in COVID-19
patients [14].
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Figure 8: Exponent α for each country vs. lung cancer death rates. We show the data points and the best-fit
for the linear interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.143 0.0121 11.8 9.96× 10−22
LUNG 0.00159 0.000381 4.17 0.0000572 0.024
R2 0.127
N 121
Estimate Standard Error t-Statistic p-value
1 0.133 0.013 10.2 7.48× 10−18
GDP 8.93× 10−7 4.02× 10−7 2.22 0.0282
LUNG 0.00122 0.000416 2.94 0.00396
R2 0.164
N 118
Cross-correlation -0.403
Table VIII: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters
of the linear interpolation, for correlation of α with lung cancer death rates, LUNG. We also show the p-
value, excluding countries below 5 thousand $ GDP per capita. In the left bottom panel: same quantities for
correlation of α with LUNG and GDP per capita. In the right panels: R2 for the best-estimate and number
of countries N . We also show the correlation coefficient between the 2 variables in the two-variable fit.
8. Obesity in males
This refers to the prevalence of obesity in adult males, measured in 2014. Results are shown in
fig. 9 and Table IX. Note that this effect is mostly due to the difference between very poor countries
and the rest of the world; indeed this becomes non-significant when excluding countries below 5K$
GDP per capita. Note also that obesity in females instead is not correlated with growth rate of
COVID-19 contagion in our sample. See also [15] for increased risk of severe COVID-19 symptoms
for obese patients.
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Figure 9: Exponent α for each country vs. prevalence of obesity in adult males. We show the data points
and the best-fit for the linear interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.134 0.0144 9.29 6.9× 10−16
OBE 0.00314 0.000788 3.98 0.000115 0.12
R2 0.114
N 125
Estimate Standard Error t-Statistic p-value
1 0.132 0.0148 8.89 8.35× 10−15
GDP 5.6× 10−7 4.84× 10−7 1.16 0.25
OBE 0.00249 0.00106 2.35 0.0202
R2 0.128
N 121
Cross-correlation -0.634
Table IX: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters of
the linear interpolation, for correlation of α with prevalence of obesity in adult males (OBE). We also show the
p-value, excluding countries below 5 thousand $ GDP per capita. In the left bottom panel: same quantities
for correlation of α with OBE and GDP per capita. In the right panels: R2 for the best-estimate and number
of countries N . We also show the correlation coefficient between the 2 variables in the two-variable fit.
9. Urbanization
This is the share of population living in urban areas, collected in year 2017. Results are shown in
Fig. 10 and Table X. This is an expected correlation, in agreement with [19, 20].
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Figure 10: Exponent α for each country vs. share of population in urban areas. We show the data points
and the best-fit for the linear interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.1 0.0228 4.4 0.0000231
URB 0.00128 0.000331 3.88 0.000173 0.057
R2 0.109
N 124
Estimate Standard Error t-Statistic p-value
1 0.108 0.0247 4.37 0.0000267
GDP 7.57× 10−7 4.74× 10−7 1.6 0.113
URB 0.000916 0.000439 2.09 0.0391
R2 0.133
N 120
Cross-correlation -0.6216
Table X: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters of
the linear interpolation, for correlation of α with share of population in urban areas, URB, as defined in the
text. We also show the p-value, excluding countries below 5 thousand $ GDP per capita. In the left bottom
panel: same quantities for correlation of α with URB and GDP per capita. In the right panels: R2 for the
best-estimate and number of countries N . We also show the correlation coefficient between the 2 variables
in the two-variable fit.
10. Alcohol consumption
This dataset refers to year 2016. Results are shown in Fig. 11 and Table XI. Note that this variable
is highly correlated with old-age dependency ratio, as discussed in section V. While the correlation
with alcohol consumption may be simply due to correlation with other variables, such as old-age
dependency ratio, this finding deserves anyway more research, to assess whether it may be at least
partially due to the deleterious effects of alcohol on the immune system.
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Figure 11: Exponent α for each country vs. alcohol consumption. We show the data points and the best-fit
for the linear interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.15 0.0131 11.4 7.8× 10−21
ALCO 0.00518 0.00164 3.17 0.00195 0.012
R2 0.076
N 126
Estimate Standard Error t-Statistic p-value
1 0.134 0.0141 9.48 3.75× 10−16
GDP 1.12× 10−6 3.86× 10−7 2.91 0.00437
ALCO 0.00382 0.0017 2.25 0.0264
R2 0.138
N 120
Cross-correlation -0.286
Table XI: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters
of the linear interpolation, for correlation of α with alcohol consumption (ALCO). We also show the p-value,
excluding countries below 5 thousand $ GDP per capita. In the left bottom panel: same quantities for
correlation of α with ALCO and GDP per capita. In the right panels: R2 for the best-estimate and number
of countries N . We also show the correlation coefficient between the 2 variables in the two-variable fit.
11. Smoking
This dataset refers to year 2012. Results are shown in Fig. 12 and Table XII. As expected this
variable is highly correlated with lung cancer, as discussed in section V. We find that COVID-19
spreads more rapidly in countries with higher daily smoking prevalence. Note however that this
becomes non-significant when excluding countries below 5K$ GDP per capita.
Correlation of α with smoking thus could be simply due to correlation with other variables or to a
bias due to lack of testing in very poor countries. Alternative interpretations are that smoking has
negative effects on conditions of lungs that facilitates contagion or that it contributes to increased
transmission of virus from hand to mouth [16]. Interestingly, note that our finding is in contrast
with claims of a possible protective effect of nicotine and smoking against COVID-19 [17, 18].
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Figure 12: Exponent α for each country vs. daily smoking prevalence. We show the data points and the
best-fit for the linear interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.132 0.0187 7.07 1.07× 10−10
SMOK 0.00278 0.000937 2.97 0.00361 0.19
R2 0.067
N 124
Estimate Standard Error t-Statistic p-value
1 0.121 0.019 6.38 3.68× 10−9
GDP 1.06× 10−6 3.89× 10−7 2.73 0.00729
SMOK 0.00209 0.000966 2.16 0.0328
R2 0.122
N 121
Cross-correlation -0.2646
Table XII: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters
of the linear interpolation, for correlation of α with daily smoking prevalence (SMOK). We also show the
p-value, excluding countries below 5 thousand $ GDP per capita. In the left bottom panel: same quantities
for correlation of α with SMOK and GDP per capita. In the right panels: R2 for the best-estimate and
number of countries N . We also show the correlation coefficient between the 2 variables in the two-variable
fit.
12. UV index
This is the UV index for the relevant period of time of the epidemic. In particular the UV index
has been collected from [21], as a monthly average, and then with a linear interpolation we have used
the average value during the 12 days of the epidemic growth, for each country. Results are shown in
Fig. 13 and Table XIII. Not surprisingly in section V we will see that such quantity is very highly
correlated with T (correlation coefficient 0.93). Note also that here the sample size is smaller (73)
than in the case of other variables, so it is not strange that the significance of a correlation with
α here is not as high as in the case of α with Temperature. More research is required to answer
more specific questions, for instance whether the virus survives less in an environment with high
UV index, or whether a high UV index stimulates vitamin D production that may help the immune
system, or both.
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Figure 13: Exponent α for each country vs. UV index for the relevant month of the epidemic. We show the
data points and the best-fit for the linear interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.249 0.0163 15.3 3.7× 10−24
UV -0.0074 0.00249 -2.97 0.00408 0.012
R2 0.110
N 73
Estimate Standard Error t-Statistic p-value
1 0.242 0.0269 9.01 2.88× 10−13
GDP 1.92× 10−7 5.8× 10−7 0.33 0.742
UV -0.00707 0.00274 -2.58 0.0119
R2 0.112
N 73
Cross-correlation 0.383
Table XIII: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters
of the linear interpolation, for correlation of α with UV index for the relevant period of time of the epidemic
(UV). We also show the p-value, excluding countries below 5 thousand $ GDP per capita. In the left bottom
panel: same quantities for correlation of α with UV and GDP per capita. In the right panels: R2 for the
best-estimate and number of countries N . We also show the correlation coefficient between the 2 variables
in the two-variable fit.
13. Vitamin D serum concentration
Another relevant variable is the amount of serum Vitamin D. We have collected data in the
literature for the average annual level of serum Vitamin D and for the seasonal level (Ds). The
seasonal level is defined as: the amount during the month of March or during winter for northern
hemisphere, or during summer for southern hemisphere or the annual level for countries with little
seasonal variation. The dataset for the annual D was built with the available literature, which is
unfortunately quite inhomogeneous as discussed in Appendix A. For many countries several studies
with quite different values were found and in this case we have collected the mean and the standard
error and a weighted average has been performed. The countries included in this dataset are 50,
as specified in Appendix. The dataset for the seasonal levels is more restricted, since the relative
literature is less complete, and we have included 42 countries.
Results are shown in Fig. 14 and Table XXXII for the annual levels and in Fig. 14 and Table XXXII
for the seasonal levels.
Interestingly, in section V we will see that D is not highly correlated with T or UV index, as
one naively could expect, due to different food consumption in different countries. A slightly higher
correlation, as it should be, is present between T and Ds. Note that our results are in agreement
with the fact that increased vitamin D levels have been proposed to have a protective effect against
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Figure 14: Exponent α for each country vs. annual levels of vitamin D, for the relevant period of time, as
defined in the text, for the base set of 42 countries. We show the data points and the best-fit for the linear
interpolation.
COVID-19 [45–47].
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.356 0.0443 8.02 2.02× 10−10
D -0.00231 0.000801 -2.88 0.00586 0.0059
R2 0.147
N 50
Estimate Standard Error t-Statistic p-value
1 0.342 0.0457 7.48 1.52× 10−9
GDP 8.29× 10−7 6.99× 10−7 1.19 0.242
D -0.00255 0.000822 -3.1 0.00328
R2 0.172
N 50
Cross-correlation -0.243
Table XIV: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters
of the linear interpolation, for correlation of α with mean annual levels of vitamin D (variable name: D).
We also show the p-value, excluding countries below 5 thousand $ GDP per capita. In the left bottom
panel: same quantities for correlation of α with D and GDP per capita. In the right panels: R2 for the
best-estimate and number of countries N . We also show the correlation coefficient between the 2 variables
in the two-variable fit.
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Figure 15: Exponent α for each country vs. seasonal levels of vitamin D, for the relevant period of time, as
defined in the text, for the base set of 42 countries. We show the data points and the best-fit for the linear
interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.385 0.0499 7.72 1.91× 10−9
Ds -0.00305 0.000949 -3.22 0.00256 0.0024
R2 0.206
N 42
Estimate Standard Error t-Statistic p-value
1 0.375 0.0533 7.03 1.94× 10−8
GDP 4.66× 10−7 8.02× 10−7 0.581 0.565
Ds -0.00314 0.00097 -3.24 0.00243
R2 0.212
N 42
Cross-correlation -0.162
Table XV: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters
of the linear interpolation, for correlation of α with mean annual levels of vitamin D (variable name: Ds).
We also show the p-value, excluding countries below 5 thousand $ GDP per capita. In the left bottom
panel: same quantities for correlation of α with Ds and GDP per capita. In the right panels: R2 for the
best-estimate and number of countries N . We also show the correlation coefficient between the 2 variables
in the two-variable fit.
14. CO2 Emissions
This is the data for year 2017. We have also checked that this has very high correlation with SO
emissions (about 0.9 correlation coefficient). We show here only the case for CO2, but the reader
should keep in mind that a very similar result applies also to SO emissions. Note also that this is
expected to have a high correlation with the number of international tourist arrivals, as we will show
in section V. Results are shown in Fig. 16 and Table XVI.
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Figure 16: Exponent α for each country vs. CO2 emissions. We show the data points and the best-fit for the
linear interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.18 0.0073 24. 9.6× 10−49
CO2 1.7× 10−11 6.9× 10−12 2.5 0.015 0.048
R2 0.048
N 110
Estimate Standard Error t-Statistic p-value
1 0.152 0.011 13.8 1.82× 10−26
GDP 1.23× 10−6 3.75× 10−7 3.29 0.00133
CO2 1.57× 10−11 6.74× 10−12 2.33 0.0214
R2 0.126
N 109
Cross-correlation -0.0321
Table XVI: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters
of the linear interpolation, for correlation of α with CO2 emissions. We also show the p-value, excluding
countries below 5 thousand $ GDP per capita. In the left bottom panel: same quantities for correlation of
α with CO2 and GDP per capita. In the right panels: R2 for the best-estimate and number of countries N .
We also show the correlation coefficient between the 2 variables in the two-variable fit.
15. Prevalence of type-1 Diabetes
This is the prevalence of type-1 Diabetes in children, 0-19 years-old, taken from [23]. Results are
shown in Fig. 17 and Table XXIII. Note however that significance becomes very small when restricting
to countries with GDP per capita larger than 5K$. Note also that in the case of diabetes of any kind
we do not find a correlation with COVID-19. Such correlation, even if not highly significant, could
be non-trivial and could constitute useful information for clinical and genetic research. See also [49].
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Figure 17: Exponent α for each country vs. prevalence of type-1 Diabetes. We show the data points and the
best-fit for the linear interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.177 0.00793 22.4 2.35× 10−41
DIAB 0.00087 0.000367 2.37 0.0198 0.072
R2 0.052
N 105
Estimate Standard Error t-Statistic p-value
1 0.142 0.0116 12.3 1.52× 10−21
GDP 1.58× 10−6 3.88× 10−7 4.08 0.000092
DIAB 0.000932 0.000349 2.67 0.00889
R2 0.189
N 101
Cross-correlation 0.0415
Table XVII: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters
of the linear interpolation, for correlation of α with prevalence of type-1 Diabetes, DIA. We also show the
p-value, excluding countries below 5 thousand $ GDP per capita. In the left bottom panel: same quantities
for correlation of α with DIA and GDP per capita. In the right panels: R2 for the best-estimate and number
of countries N . We also show the correlation coefficient between the 2 variables in the two-variable fit.
16. Tuberculosis (BCG) vaccination coverage
This dataset is the vaccination coverage for tuberculosis for year 2015 [55]. Results are shown in
Fig. 18 and Table XVIII. This correlation, even if not highly significant and to be confirmed by more
data, is also quite non-trivial and could be useful information for clinical and genetic research (see
also [29–31]) and even for vaccine development [32–34].
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Figure 18: Exponent α for each country vs. BCG vaccination coverage. We show the data points and the
best-fit for the linear interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.289 0.053 5.46 3.99× 10−7
BCG -0.00129 0.000579 -2.22 0.0286 0.011
R2 0.051
N 94
Estimate Standard Error t-Statistic p-value
1 0.28 0.0534 5.24 1.07× 10−6
GDP 8.53× 10−7 4.79× 10−7 1.78 0.0781
BCG -0.00134 0.00058 -2.3 0.0235
R2 0.084
N 92
Cross-correlation -0.0367
Table XVIII: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters
of the linear interpolation, for correlation of α with BCG vaccination coverage (BCG). We also show the
p-value, excluding countries below 5 thousand $ GDP per capita. In the left bottom panel: same quantities
for correlation of α with BCG and GDP per capita. In the right panels: R2 for the best-estimate and number
of countries N . We also show the correlation coefficient between the 2 variables in the two-variable fit.
A. “Counterintuitive” correlations
We show here other correlations that are somehow counterintuitive, since they go in the opposite
direction than from a naive expectation. We will try to interpret these results in section V.
1. Death rate from air pollution
This dataset is for year 2015. Results are shown in Fig. 19 and Table XIX. Contrary to naive
expectations and to claims in the opposite direction [48], we find that countries with larger death
rate from air pollution actually have slower COVID-19 contagion.
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Figure 19: Exponent α for each country vs. death rate from air pollution per 100000. We show the data
points and the best-fit for the linear interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.216 0.0102 21.3 8.97× 10−43
POLL -0.000394 0.0000917 -4.29 0.0000357 0.040
R2 0.132
N 123
Estimate Standard Error t-Statistic p-value
1 0.211 0.0204 10.3 3.75× 10−18
GDP 3.13× 10−7 4.77× 10−7 0.655 0.514
POLL -0.000418 0.000131 -3.19 0.00185
R2 0.158
N 120
Cross-correlation 0.630
Table XIX: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters
of the linear interpolation, for correlation of α with death rate from air pollution per 100000 (POLL). We
also show the p-value, excluding countries below 5 thousand $ GDP per capita. In the left bottom panel:
same quantities for correlation of α with POLL and GDP per capita. In the right panels: R2 for the best-
estimate and number of countries N . We also show the correlation coefficient between the 2 variables in the
two-variable fit.
2. High blood pressure in females
This dataset is for year 2015. Results are shown in Fig. 20 and Table XX. Countries with larger
share of high blood pressure in females have slower COVID-19 contagion. Note that we do not find
a significant correlation instead with high blood pressure in males.
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Figure 20: Exponent α for each country vs. share of women with high blood pressure. We show the data
points and the best-fit for the linear interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.284 0.0265 10.7 2.76× 10−19
PRE -0.00482 0.00124 -3.89 0.000164 0.028
R2 0.109
N 125
Estimate Standard Error t-Statistic p-value
1 0.248 0.0432 5.75 7.2× 10−8
GDP 5.85× 10−7 4.89× 10−7 1.2 0.234
PRE -0.00372 0.00168 -2.22 0.0284
R2 0.123
N 121
Cross-correlation 0.642
Table XX: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters
of the linear interpolation, for correlation of α with share of women with high blood pressure (PRE). We
also show the p-value, excluding countries below 5 thousand $ GDP per capita. In the left bottom panel:
same quantities for correlation of α with PRE and GDP per capita. In the right panels: R2 for the best-
estimate and number of countries N . We also show the correlation coefficient between the 2 variables in the
two-variable fit.
3. Hepatitis B incidence rate
This is the incidence of hepatitis B, measured as the number of new cases of hepatitis B per 100,000
individuals in a given population, for the year 2015. Results are shown in Fig. 21 and Table XXI.
Countries with higher incidence of hepatitis B have slower contagion of COVID-19.
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Figure 21: Exponent α for each country vs. incidence of Hepatitis B, for the relevant period of time, as
defined in the text, for the base set of 42 countries. We show the data points and the best-fit for the linear
interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.215 0.0107 20.1 1.16× 10−40
HEP -0.000021 5.56× 10−6 -3.78 0.000243 0.016
R2 0.104
N 125
Estimate Standard Error t-Statistic p-value
1 0.189 0.017 11.1 5.02× 10−20
GDP 8.39× 10−7 4.1× 10−7 2.05 0.0429
HEP -0.0000161 6.21× 10−6 -2.58 0.011
R2 0.136
N 121
Cross-correlation 0.420
Table XXI: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters
of the linear interpolation, for correlation of α with incidence of Hepatitis B (HEP). We also show the p-
value, excluding countries below 5 thousand $ GDP per capita. In the left bottom panel: same quantities for
correlation of α with HEP and GDP per capita. In the right panels: R2 for the best-estimate and number
of countries N . We also show the correlation coefficient between the 2 variables in the two-variable fit.
4. Prevalence of Anemia
Prevalence of anemia in children in 2016, measured as the share of children under the age of
five with hemoglobin levels less than 110 grams per liter at sea level. A similar but less significant
correlation is found also with anemia in adults, which we do not report here. Results are shown in
Fig. 22 and Table XXII. The significance is quite high, but could be interpreted as due to a high
correlation with life expectancy, as we explain in section V. A different hypothesis is that this might
be related to genetic factors, which might affect the immune response to COVID-19.
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Figure 22: Exponent α for each country vs. prevalence of anemia in children. We show the data points and
the best-fit for the linear interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.24 0.0136 17.7 1.58× 10−35
ANE -0.00181 0.000386 -4.7 6.95× 10−6 0.0014
R2 0.153
N 124
Estimate Standard Error t-Statistic p-value
1 0.22 0.0249 8.83 1.23× 10−14
GDP 4.97× 10−7 4.74× 10−7 1.05 0.297
ANE -0.00148 0.000514 -2.89 0.0046
R2 0.161
N 120
Cross-correlation 0.638
Table XXII: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters
of the linear interpolation, for correlation of α with prevalence of anemia in children (ANE). We also show the
p-value, excluding countries below 5 thousand $ GDP per capita. In the left bottom panel: same quantities
for correlation of α with ANE and GDP per capita. In the right panels: R2 for the best-estimate and number
of countries N . We also show the correlation coefficient between the 2 variables in the two-variable fit.
B. Blood types
Blood types are not equally distributed in the world and thus we have correlated them with α.
Data were taken from [50]. Very interestingly we find significant correlations, especially for blood
types B+ (slower COVID-19 contagion) and A- (faster COVID-19 contagion). In general also all
RH-negative blood types correlate with faster COVID-19 contagion. It is interesting to compare
with findings in clinical data: (i) our finding that blood type A is associated with a higher risk for
acquiring COVID-19 is in good agreement with [26], (ii) we find higher risk for group 0- and no
correlation for group 0+ (while [26] finds lower risk higher risk for groups 0), (iii) we have a strong
significance for lower risk for RH+ types and in particular lower risk for group B+, which is probably
a new finding, to our knowledge. These are also non-trivial findings which should stimulate further
medical research on the immune response of different blood-types against COVID-19.
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Figure 23: Exponent α for each country vs. percentage of population with blood type A+. We show the
data points and the best-fit for the linear interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.0892 0.0367 2.43 0.0172
A+ 0.00372 0.00118 3.15 0.00225 0.011
R2 0.100
N 91
Estimate Standard Error t-Statistic p-value
1 0.0907 0.0363 2.5 0.0144
GDP 9.42× 10−7 4.8× 10−7 1.96 0.0528
A+ 0.00292 0.00124 2.34 0.0214
R2 0.139
N 90
Cross-correlation -0.340
Table XXIII: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters
of the linear interpolation, for correlation of α with percentage of population with blood type A+. We also
show the p-value, excluding countries below 5 thousand $ GDP per capita. In the left bottom panel: same
quantities for correlation of α with A+ blood and GDP per capita. In the right panels: R2 for the best-
estimate and number of countries N . We also show the correlation coefficient between the 2 variables in the
two-variable fit.
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Figure 24: Exponent α for each country vs. percentage of population with blood type B+. We show the
data points and the best-fit for the linear interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.262 0.0176 14.9 7.3× 10−26
B+ -0.00398 0.00104 -3.84 0.000233 0.0014
R2 0.142
N 91
Estimate Standard Error t-Statistic p-value
1 0.232 0.0237 9.78 1.15× 10−15
GDP 9.15× 10−7 4.6× 10−7 1.99 0.0495
B+ -0.00341 0.00107 -3.18 0.00202
R2 0.181
N 90
Cross-correlation 0.285
Table XXIV: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters
of the linear interpolation, for correlation of α with percentage of population with blood type B+. We also
show the p-value, excluding countries below 5 thousand $ GDP per capita. In the left bottom panel: same
quantities for correlation of α with B+ and GDP per capita. In the right panels: R2 for the best-estimate and
number of countries N . We also show the correlation coefficient between the 2 variables in the two-variable
fit.
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Figure 25: Exponent α for each country vs. percentage of population with blood type 0-. We show the data
points and the best-fit for the linear interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.148 0.0155 9.52 3.1× 10−15
0- 0.0127 0.00316 4.04 0.000115 0.0058
R2 0.155
N 91
Estimate Standard Error t-Statistic p-value
1 0.14 0.0166 8.45 5.86× 10−13
GDP 6.84× 10−7 4.9× 10−7 1.4 0.166
0- 0.0106 0.0035 3.04 0.00315
R2 0.173
N 90
Cross-correlation -0.430
Table XXV: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters
of the linear interpolation, for correlation of α with percentage of population with blood type 0−. We also
show the p-value, excluding countries below 5 thousand $ GDP per capita. In the left bottom panel: same
quantities for correlation of α with 0− and GDP per capita. In the right panels: R2 for the best-estimate and
number of countries N . We also show the correlation coefficient between the 2 variables in the two-variable
fit.
30
4. Type A-
0 2 4 6 8
0.0
0.1
0.2
0.3
0.4
Percentage of population with A- blood type
Ex
po
ne
nt
α(firs
t1
2
da
ys
)
Figure 26: Exponent α for each country vs. percentage of population with blood type A-. We show the data
points and the best-fit for the linear interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.153 0.0136 11.3 7.3× 10−19
A- 0.0131 0.00298 4.38 0.0000327 0.0027
R2 0.177
N 91
Estimate Standard Error t-Statistic p-value
1 0.146 0.0151 9.6 2.59× 10−15
GDP 6.× 10−7 4.88× 10−7 1.23 0.222
A- 0.0112 0.00334 3.37 0.00113
R2 0.191
N 90
Cross-correlation -0.441
Table XXVI: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters
of the linear interpolation, for correlation of α with percentage of population with blood type A-. We also
show the p-value, excluding countries below 5 thousand $ GDP per capita. In the left bottom panel: same
quantities for correlation of α with A- and GDP per capita. In the right panels: R2 for the best-estimate and
number of countries N . We also show the correlation coefficient between the 2 variables in the two-variable
fit.
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5. Type B-
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Figure 27: Exponent α for each country vs. percentage of population with blood type B-. We show the data
points and the best-fit for the linear interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.17 0.0154 11. 2.35× 10−18
B- 0.0224 0.00908 2.47 0.0156 0.14
R2 0.064
N 91
Estimate Standard Error t-Statistic p-value
1 0.147 0.0176 8.36 9.28× 10−13
GDP 1.16× 10−6 4.62× 10−7 2.51 0.0139
B- 0.0183 0.00901 2.03 0.0451
R2 0.127
N 90
Cross-correlation -0.175
Table XXVII: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parame-
ters of the linear interpolation, for correlation of α with percentage of population with blood type B-. We also
show the p-value, excluding countries below 5 thousand $ GDP per capita. In the left bottom panel: same
quantities for correlation of α with B- and GDP per capita. In the right panels: R2 for the best-estimate and
number of countries N . We also show the correlation coefficient between the 2 variables in the two-variable
fit.
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6. Type AB-
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Figure 28: Exponent α for each country vs. percentage of population with blood type AB-. We show the
data points and the best-fit for the linear interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.165 0.014 11.8 8.29× 10−20
AB- 0.0668 0.0208 3.22 0.00181 0.027
R2 0.104
N 91
Estimate Standard Error t-Statistic p-value
1 0.151 0.0159 9.48 4.73× 10−15
GDP 9.18× 10−7 4.84× 10−7 1.9 0.0612
AB- 0.0517 0.0222 2.33 0.0221
R2 0.139
N 90
Cross-correlation -0.360
Table XXVIII: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the pa-
rameters of the linear interpolation, for correlation of α with percentage of population with blood type AB-.
We also show the p-value, excluding countries below 5 thousand $ GDP per capita. In the left bottom
panel: same quantities for correlation of α with AB- and GDP per capita. In the right panels: R2 for the
best-estimate and number of countries N . We also show the correlation coefficient between the 2 variables
in the two-variable fit.
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Figure 29: Exponent α for each country vs. percentage of population with RH-positive blood. We show the
data points and the best-fit for the linear interpolation.
Estimate Standard Error t-Statistic p-value p-value, GDP>5K$
1 0.727 0.116 6.28 1.22× 10−8
RH+ -0.00583 0.00128 -4.55 0.0000171 0.0035
R2 0.188
N 91
Estimate Standard Error t-Statistic p-value
1 0.646 0.135 4.79 6.8× 10−6
GDP 5.74× 10−7 4.84× 10−7 1.19 0.238
RH+ -0.00508 0.00143 -3.55 0.000625
R2 0.201
N 90
Cross-correlation 0.437
Table XXIX: In the left top panel: best-estimate, standard error (σ), t-statistic and p-value for the parameters
of the linear interpolation, for correlation of α with percentage of population with RH-positive blood (RH+).
We also show the p-value, excluding countries below 5 thousand $ GDP per capita. In the left bottom
panel: same quantities for correlation of α with RH+ and GDP per capita. In the right panels: R2 for the
best-estimate and number of countries N . We also show the correlation coefficient between the 2 variables
in the two-variable fit.
V. CROSS-CORRELATIONS
In this section we first perform linear fits of α with each possible pair of variables (excluding the
ones which were not significant when combined with GDP per capita and considering only RH+ and
B+ for blood types). We show the correlation coefficients between the two variables, for each pair,
in Fig. 30. We also show the p-value of the t-statistic of each pair of variables and the total R2 of
such fits in Fig. 31.
We give here below possible interpretations of the redundancy among our variables and we perform
multiple variable fits in the following subsections.
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T OLD LIFE ARR DATE GRE LUNG OBE URB UV GDP ALCO SMOK ANE POLL HEP PRE D Ds CO2 DIAB BCG RH+ B+ α p- value
T 1 0.7 0.53 0.27 -0.38 0.25 0.72 0.5 0.33 -0.93 0.43 0.54 0.61 -0.61 -0.42 -0.45 -0.32 -0.071 -0.29 0.18 5×10-3 2×10-3 -0.66 -0.34 -0.43 4×10-7
OLD 0.7 1 -0.68 -0.35 0.41 -0.25 -0.74 -0.47 -0.4 0.69 -0.46 -0.71 -0.57 0.66 0.59 0.6 0.49 -0.25 0.018 -0.054 0.011 0.15 0.64 0.4 0.4 3×10-6
LIFE 0.53 -0.68 1 -0.31 0.58 -0.19 -0.56 -0.69 -0.65 0.41 -0.68 -0.32 -0.48 0.9 0.84 0.74 0.78 -0.29 -0.16 -0.076 -0.035 -0.2 0.46 0.38 0.39 8×10-6
ARR 0.27 -0.35 -0.31 1 0.61 0.036 -0.3 -0.19 -0.19 0.13 -0.29 -0.18 -0.23 0.34 0.25 0.16 0.34 -0.051 4×10-3 -0.54 -0.29 -0.025 0.11 0.045 0.41 1×10-5
DATE -0.38 0.41 0.58 0.61 1 -0.18 0.37 0.26 0.42 -0.031 0.54 0.2 0.31 -0.57 -0.46 -0.19 -0.57 0.14 -6×10-3 0.54 0.26 0.11 -0.044 0.1 -0.37 2×10-5
GRE 0.25 -0.25 -0.19 0.036 -0.18 1 -0.28 -0.45 -0.29 0.38 6×10-3 -0.34 -0.2 0.27 0.36 0.47 0.13 0.2 0.19 0.11 0.026 0.035 0.49 0.57 0.36 5×10-5
LUNG 0.72 -0.74 -0.56 -0.3 0.37 -0.28 1 -0.5 -0.35 0.63 -0.4 -0.6 -0.76 0.6 0.5 0.48 0.32 -0.08 0.15 -0.11 0.036 -0.11 0.57 0.17 0.36 6×10-5
OBE 0.5 -0.47 -0.69 -0.19 0.26 -0.45 -0.5 1 -0.74 0.5 -0.63 -0.34 -0.44 0.69 0.73 0.65 0.56 -7×10-4 0.032 -3×10-4 0.067 -0.14 0.72 0.62 0.34 1×10-4
URB 0.33 -0.4 -0.65 -0.19 0.42 -0.29 -0.35 -0.74 1 0.16 -0.62 -0.17 -0.29 0.63 0.71 0.59 0.77 -0.11 -0.13 -0.031 0.031 -0.071 0.36 0.5 0.33 2×10-4
UV -0.93 0.69 0.41 0.13 -0.031 0.38 0.63 0.5 0.16 1 0.38 0.6 0.47 -0.49 -0.33 -0.36 -0.11 -0.077 -0.25 0.022 -0.18 -0.23 -0.67 -0.34 -0.33 4×10-3
GDP 0.43 -0.46 -0.68 -0.29 0.54 6×10-3 -0.4 -0.63 -0.62 0.38 1 -0.29 -0.26 0.64 0.63 0.42 0.64 -0.24 -0.16 -0.061 0.042 -0.037 0.44 0.29 0.29 1×10-3
ALCO 0.54 -0.71 -0.32 -0.18 0.2 -0.34 -0.6 -0.34 -0.17 0.6 -0.29 1 -0.41 0.4 0.36 0.39 0.3 -0.28 -0.064 -0.05 -2×10-3 0.13 0.55 0.38 0.27 2×10-3
SMOK 0.61 -0.57 -0.48 -0.23 0.31 -0.2 -0.76 -0.44 -0.29 0.47 -0.26 -0.41 1 0.54 0.43 0.4 0.22 0.31 0.38 -0.073 0.042 -0.13 0.38 0.056 0.26 4×10-3
ANE -0.61 0.66 0.9 0.34 -0.57 0.27 0.6 0.69 0.63 -0.49 0.64 0.4 0.54 1 -0.82 -0.77 -0.78 0.29 0.23 0.12 -7×10-3 0.12 -0.51 -0.43 -0.39 6×10-6
POLL -0.42 0.59 0.84 0.25 -0.46 0.36 0.5 0.73 0.71 -0.33 0.63 0.36 0.43 -0.82 1 -0.66 -0.75 0.28 0.28 4×10-3 -0.04 0.13 -0.5 -0.49 -0.37 3×10-5
HEP -0.45 0.6 0.74 0.16 -0.19 0.47 0.48 0.65 0.59 -0.36 0.42 0.39 0.4 -0.77 -0.66 1 -0.57 -0.077 -0.1 -0.042 0.07 0.075 -0.55 -0.45 -0.32 2×10-4
PRE -0.32 0.49 0.78 0.34 -0.57 0.13 0.32 0.56 0.77 -0.11 0.64 0.3 0.22 -0.78 -0.75 -0.57 1 0.32 0.32 0.17 0.029 0.065 -0.15 -0.41 -0.33 2×10-4
D -0.071 -0.25 -0.29 -0.051 0.14 0.2 -0.08 -7×10-4 -0.11 -0.077 -0.24 -0.28 0.31 0.29 0.28 -0.077 0.32 1 -0.91 -0.012 0.083 0.14 -0.047 3×10-3 -0.38 6×10-3
Ds -0.29 0.018 -0.16 4×10-3 -6×10-3 0.19 0.15 0.032 -0.13 -0.25 -0.16 -0.064 0.38 0.23 0.28 -0.1 0.32 -0.91 1 0.062 0.074 0.15 -0.035 -5×10-3 -0.46 2×10-3
CO2 0.18 -0.054 -0.076 -0.54 0.54 0.11 -0.11 -3×10-4 -0.031 0.022 -0.061 -0.05 -0.073 0.12 4×10-3 -0.042 0.17 -0.012 0.062 1 -0.45 -0.062 -0.12 -0.097 0.22 0.016
DIAB 5×10-3 0.011 -0.035 -0.29 0.26 0.026 0.036 0.067 0.031 -0.18 0.042 -2×10-3 0.042 -7×10-3 -0.04 0.07 0.029 0.083 0.074 -0.45 1 -0.029 0.021 -0.18 0.23 0.02
BCG 2×10-3 0.15 -0.2 -0.025 0.11 0.035 -0.11 -0.14 -0.071 -0.23 -0.037 0.13 -0.13 0.12 0.13 0.075 0.065 0.14 0.15 -0.062 -0.029 1 -0.13 -0.15 -0.22 0.031
RH+ -0.66 0.64 0.46 0.11 -0.044 0.49 0.57 0.72 0.36 -0.67 0.44 0.55 0.38 -0.51 -0.5 -0.55 -0.15 -0.047 -0.035 -0.12 0.021 -0.13 1 -0.55 -0.44 2×10-5
B+ -0.34 0.4 0.38 0.045 0.1 0.57 0.17 0.62 0.5 -0.34 0.29 0.38 0.056 -0.43 -0.49 -0.45 -0.41 3×10-3 -5×10-3 -0.097 -0.18 -0.15 -0.55 1 -0.38 2×10-4
α -0.43 0.4 0.39 0.41 -0.37 0.36 0.36 0.34 0.33 -0.33 0.29 0.27 0.26 -0.39 -0.37 -0.32 -0.33 -0.38 -0.46 0.22 0.23 -0.22 -0.44 -0.38 1 0
p- value 4×10-7 3×10-6 8×10-6 1×10-5 2×10-5 5×10-5 6×10-5 1×10-4 2×10-4 4×10-3 1×10-3 2×10-3 4×10-3 6×10-6 3×10-5 2×10-4 2×10-4 6×10-3 2×10-3 0.016 0.02 0.031 2×10-5 2×10-4 0
Figure 30: Correlation coefficients between each pair of variables. Such coefficient corresponds to the off-
diagonal entry of the (normalized) covariance matrix, multiplied by −1. In the last column and row we
show the p-value of each variable when performing a one-variable linear fit for the growth rate α. Note also
that the fits that include vitamin D variables (D and Ds) and UV index are based on smaller samples than
for the other fits, as explained in the text. The variables considered here are: Temperature (T), Old age
dependency ratio (OLD), Life expectancy (LIFE), Number of tourist arrivals (ARR), Starting date of the
epidemic (DATE), Amount of contact in greeting habits (GRE), Lung cancer (LUNG), Obesity in males
(OBE), Urbanization (URB), UV Index (UV), GDP per capita (GDP), Alcohol consumption (ALCO), Daily
smoking prevalence (SMOK), Prevalence of anemia in children (ANE), Death rate due to pollution (POLL),
Prevalence of hepatitis B (HEP), High blood pressure in females (PRE), average vitamin D serum levels
(D), seasonal vitamin D serum levels (Ds), CO2 emissions (CO2), type 1 diabetes prevalence (DIAB), BCG
vaccination (BCG), percentage with blood of RH+ type (RH+), percentage with blood type B+ (B+).
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T OLD LIFE ARR DATE GRE LUNG OBE URB UV GDP ALCO SMOK ANE POLL HEP PRE D Ds CO2 DIAB BCG RH+ B+
T p = 4×10-7
R2= 0.19
pV = 5×10-3
pH = 0.11
R2= 0.22
pV = 5×10-4
pH = 0.025
R2= 0.23
pV = 4×10-5
pH = 4×10-4
R2= 0.29
pV = 1×10-4
pH = 5×10-3
R2= 0.24
pV = 2×10-5
pH = 1×10-3
R2= 0.25
pV = 7×10-4
pH = 0.62
R2= 0.21
pV = 1×10-4
pH = 0.097
R2= 0.22
pV = 1×10-5
pH = 0.015
R2= 0.24
pV = 0.23
pH = 0.98
R2= 0.13
pV = 3×10-5
pH = 0.16
R2= 0.21
pV = 2×10-5
pH = 0.68
R2= 0.2
pV = 1×10-5
pH = 0.81
R2= 0.2
pV = 1×10-3
pH = 0.063
R2= 0.22
pV = 1×10-4
pH = 0.014
R2= 0.24
pV = 5×10-5
pH = 0.09
R2= 0.22
pV = 1×10-5
pH = 0.013
R2= 0.24
pV = 3×10-3
pH = 6×10-3
R2= 0.3
pV = 0.018
pH = 0.014
R2= 0.32
pV = 1×10-6
pH = 0.084
R2= 0.22
pV = 2×10-5
pH = 0.012
R2= 0.21
pV = 2×10-4
pH = 0.02
R2= 0.19
pV = 0.012
pH = 0.069
R2= 0.25
pV = 2×10-4
pH = 0.012
R2= 0.27
OLD
pV = 0.11
pH = 5×10-3
R2= 0.22
p = 3×10-6
R2= 0.16
pV = 0.022
pH = 0.055
R2= 0.19
pV = 4×10-3
pH = 7×10-4
R2= 0.23
pV = 1×10-3
pH = 2×10-3
R2= 0.23
pV = 2×10-4
pH = 9×10-4
R2= 0.23
pV = 9×10-3
pH = 0.36
R2= 0.18
pV = 8×10-4
pH = 0.055
R2= 0.19
pV = 4×10-4
pH = 0.025
R2= 0.2
pV = 0.97
pH = 0.031
R2= 0.12
pV = 6×10-4
pH = 0.08
R2= 0.19
pV = 4×10-4
pH = 0.79
R2= 0.17
pV = 2×10-4
pH = 0.72
R2= 0.17
pV = 0.019
pH = 0.043
R2= 0.19
pV = 9×10-3
pH = 0.035
R2= 0.19
pV = 9×10-4
pH = 0.42
R2= 0.17
pV = 2×10-3
pH = 0.027
R2= 0.2
pV = 0.26
pH = 1×10-2
R2= 0.14
pV = 0.75
pH = 9×10-3
R2= 0.17
pV = 4×10-6
pH = 0.017
R2= 0.2
pV = 2×10-6
pH = 8×10-3
R2= 0.25
pV = 0.031
pH = 0.063
R2= 0.097
pV = 0.3
pH = 1×10-2
R2= 0.18
pV = 0.029
pH = 0.014
R2= 0.18
LIFE
pV = 0.025
pH = 5×10-4
R2= 0.23
pV = 0.055
pH = 0.022
R2= 0.19
p = 8×10-6
R2= 0.15
pV = 5×10-4
pH = 6×10-4
R2= 0.26
pV = 0.018
pH = 0.01
R2= 0.2
pV = 1×10-4
pH = 4×10-4
R2= 0.24
pV = 5×10-3
pH = 0.053
R2= 0.18
pV = 8×10-3
pH = 0.33
R2= 0.16
pV = 7×10-3
pH = 0.23
R2= 0.16
pV = 0.35
pH = 0.017
R2= 0.13
pV = 4×10-3
pH = 0.45
R2= 0.16
pV = 2×10-4
pH = 0.066
R2= 0.18
pV = 4×10-4
pH = 0.37
R2= 0.16
pV = 0.29
pH = 0.27
R2= 0.16
pV = 0.13
pH = 0.25
R2= 0.16
pV = 3×10-3
pH = 0.91
R2= 0.15
pV = 0.033
pH = 0.32
R2= 0.16
pV = 0.15
pH = 7×10-3
R2= 0.16
pV = 0.14
pH = 4×10-3
R2= 0.21
pV = 1×10-5
pH = 0.022
R2= 0.19
pV = 6×10-6
pH = 0.017
R2= 0.23
pV = 6×10-4
pH = 4×10-3
R2= 0.16
pV = 0.048
pH = 4×10-3
R2= 0.21
pV = 0.015
pH = 0.013
R2= 0.19
ARR
pV = 4×10-4
pH = 4×10-5
R2= 0.29
pV = 7×10-4
pH = 4×10-3
R2= 0.23
pV = 6×10-4
pH = 5×10-4
R2= 0.26
p = 1×10-5
R2= 0.17
pV = 0.033
pH = 0.01
R2= 0.22
pV = 2×10-6
pH = 5×10-5
R2= 0.29
pV = 3×10-4
pH = 0.012
R2= 0.22
pV = 8×10-5
pH = 7×10-4
R2= 0.25
pV = 8×10-5
pH = 6×10-4
R2= 0.25
pV = 2×10-3
pH = 0.014
R2= 0.23
pV = 3×10-4
pH = 7×10-3
R2= 0.22
pV = 4×10-5
pH = 0.088
R2= 0.19
pV = 8×10-5
pH = 0.049
R2= 0.2
pV = 1×10-3
pH = 4×10-4
R2= 0.26
pV = 3×10-4
pH = 6×10-5
R2= 0.28
pV = 4×10-5
pH = 6×10-3
R2= 0.22
pV = 6×10-4
pH = 5×10-3
R2= 0.23
pV = 0.056
pH = 0.011
R2= 0.18
pV = 0.24
pH = 8×10-3
R2= 0.2
pV = 2×10-4
pH = 0.97
R2= 0.17
pV = 1×10-5
pH = 0.33
R2= 0.24
pV = 8×10-4
pH = 0.034
R2= 0.18
pV = 2×10-3
pH = 8×10-4
R2= 0.24
pV = 1×10-3
pH = 1×10-3
R2= 0.23
DATE
pV = 5×10-3
pH = 1×10-4
R2= 0.24
pV = 2×10-3
pH = 1×10-3
R2= 0.23
pV = 0.01
pH = 0.018
R2= 0.2
pV = 0.01
pH = 0.033
R2= 0.22
p = 2×10-5
R2= 0.14
pV = 8×10-8
pH = 9×10-8
R2= 0.32
pV = 7×10-4
pH = 7×10-3
R2= 0.21
pV = 5×10-4
pH = 2×10-3
R2= 0.2
pV = 7×10-4
pH = 0.028
R2= 0.19
pV = 0.53
pH = 5×10-3
R2= 0.12
pV = 4×10-3
pH = 0.19
R2= 0.15
pV = 3×10-5
pH = 0.017
R2= 0.2
pV = 4×10-4
pH = 0.076
R2= 0.16
pV = 9×10-3
pH = 0.015
R2= 0.2
pV = 8×10-3
pH = 8×10-3
R2= 0.18
pV = 2×10-4
pH = 2×10-3
R2= 0.2
pV = 9×10-3
pH = 0.077
R2= 0.16
pV = 0.7
pH = 6×10-3
R2= 0.15
pV = 0.97
pH = 3×10-3
R2= 0.21
pV = 6×10-4
pH = 0.81
R2= 0.14
pV = 5×10-3
pH = 0.11
R2= 0.12
pV = 3×10-4
pH = 7×10-3
R2= 0.18
pV = 3×10-3
pH = 1×10-5
R2= 0.27
pV = 4×10-4
pH = 2×10-5
R2= 0.25
GRE
pV = 1×10-3
pH = 2×10-5
R2= 0.25
pV = 9×10-4
pH = 2×10-4
R2= 0.23
pV = 4×10-4
pH = 1×10-4
R2= 0.24
pV = 5×10-5
pH = 2×10-6
R2= 0.29
pV = 9×10-8
pH = 8×10-8
R2= 0.32
p = 5×10-5
R2= 0.13
pV = 7×10-4
pH = 5×10-3
R2= 0.2
pV = 4×10-3
pH = 0.039
R2= 0.17
pV = 1×10-3
pH = 4×10-3
R2= 0.19
pV = 2×10-4
pH = 0.11
R2= 0.29
pV = 1×10-5
pH = 8×10-4
R2= 0.22
pV = 9×10-4
pH = 0.048
R2= 0.17
pV = 2×10-4
pH = 0.058
R2= 0.16
pV = 1×10-3
pH = 5×10-4
R2= 0.22
pV = 2×10-3
pH = 6×10-3
R2= 0.19
pV = 4×10-3
pH = 0.061
R2= 0.16
pV = 9×10-5
pH = 8×10-4
R2= 0.22
pV = 4×10-3
pH = 0.02
R2= 0.29
pV = 1×10-3
pH = 5×10-3
R2= 0.4
pV = 4×10-6
pH = 2×10-3
R2= 0.2
pV = 7×10-7
pH = 8×10-3
R2= 0.26
pV = 3×10-4
pH = 0.016
R2= 0.19
pV = 0.075
pH = 4×10-3
R2= 0.21
pV = 0.085
pH = 0.028
R2= 0.18
LUNG
pV = 0.62
pH = 7×10-4
R2= 0.21
pV = 0.36
pH = 9×10-3
R2= 0.18
pV = 0.053
pH = 5×10-3
R2= 0.18
pV = 0.012
pH = 3×10-4
R2= 0.22
pV = 7×10-3
pH = 7×10-4
R2= 0.21
pV = 5×10-3
pH = 7×10-4
R2= 0.2
p = 6×10-5
R2= 0.13
pV = 0.011
pH = 0.037
R2= 0.16
pV = 3×10-3
pH = 8×10-3
R2= 0.18
pV = 0.28
pH = 3×10-3
R2= 0.14
pV = 4×10-3
pH = 0.028
R2= 0.16
pV = 7×10-3
pH = 0.36
R2= 0.13
pV = 7×10-3
pH = 0.95
R2= 0.13
pV = 0.08
pH = 8×10-3
R2= 0.18
pV = 0.029
pH = 5×10-3
R2= 0.18
pV = 6×10-3
pH = 0.086
R2= 0.15
pV = 2×10-3
pH = 2×10-3
R2= 0.19
pV = 0.47
pH = 0.015
R2= 0.13
pV = 0.9
pH = 1×10-2
R2= 0.17
pV = 1×10-4
pH = 0.034
R2= 0.16
pV = 5×10-5
pH = 9×10-3
R2= 0.2
pV = 4×10-3
pH = 0.011
R2= 0.14
pV = 0.63
pH = 2×10-3
R2= 0.18
pV = 0.026
pH = 1×10-3
R2= 0.18
OBE
pV = 0.097
pH = 1×10-4
R2= 0.22
pV = 0.055
pH = 8×10-4
R2= 0.19
pV = 0.33
pH = 8×10-3
R2= 0.16
pV = 7×10-4
pH = 8×10-5
R2= 0.25
pV = 2×10-3
pH = 5×10-4
R2= 0.2
pV = 0.039
pH = 4×10-3
R2= 0.17
pV = 0.037
pH = 0.011
R2= 0.16
p = 1×10-4
R2= 0.11
pV = 0.14
pH = 0.12
R2= 0.13
pV = 0.34
pH = 0.041
R2= 0.12
pV = 0.02
pH = 0.25
R2= 0.13
pV = 3×10-3
pH = 0.047
R2= 0.14
pV = 3×10-3
pH = 0.17
R2= 0.13
pV = 0.32
pH = 7×10-3
R2= 0.16
pV = 0.23
pH = 0.041
R2= 0.14
pV = 0.05
pH = 0.11
R2= 0.13
pV = 0.029
pH = 0.042
R2= 0.14
pV = 0.04
pH = 5×10-3
R2= 0.22
pV = 0.047
pH = 2×10-3
R2= 0.28
pV = 7×10-5
pH = 0.01
R2= 0.16
pV = 8×10-6
pH = 4×10-3
R2= 0.22
pV = 7×10-4
pH = 7×10-3
R2= 0.16
pV = 0.55
pH = 8×10-3
R2= 0.19
pV = 0.12
pH = 0.043
R2= 0.17
URB
pV = 0.015
pH = 1×10-5
R2= 0.24
pV = 0.025
pH = 4×10-4
R2= 0.2
pV = 0.23
pH = 7×10-3
R2= 0.16
pV = 6×10-4
pH = 8×10-5
R2= 0.25
pV = 0.028
pH = 7×10-4
R2= 0.19
pV = 4×10-3
pH = 1×10-3
R2= 0.19
pV = 8×10-3
pH = 3×10-3
R2= 0.18
pV = 0.12
pH = 0.14
R2= 0.13
p = 2×10-4
R2= 0.11
pV = 0.51
pH = 4×10-3
R2= 0.13
pV = 0.035
pH = 0.12
R2= 0.13
pV = 6×10-4
pH = 0.011
R2= 0.16
pV = 1×10-3
pH = 0.054
R2= 0.14
pV = 0.19
pH = 6×10-3
R2= 0.17
pV = 0.29
pH = 0.017
R2= 0.15
pV = 0.023
pH = 0.15
R2= 0.13
pV = 0.29
pH = 0.065
R2= 0.14
pV = 0.13
pH = 0.01
R2= 0.16
pV = 0.046
pH = 3×10-3
R2= 0.25
pV = 1×10-4
pH = 0.014
R2= 0.16
pV = 5×10-4
pH = 0.011
R2= 0.16
pV = 2×10-3
pH = 0.014
R2= 0.14
pV = 0.046
pH = 1×10-3
R2= 0.21
pV = 0.08
pH = 0.022
R2= 0.16
UV
pV = 0.98
pH = 0.23
R2= 0.13
pV = 0.031
pH = 0.97
R2= 0.12
pV = 0.017
pH = 0.35
R2= 0.13
pV = 0.014
pH = 2×10-3
R2= 0.23
pV = 5×10-3
pH = 0.53
R2= 0.12
pV = 0.11
pH = 2×10-4
R2= 0.29
pV = 3×10-3
pH = 0.28
R2= 0.14
pV = 0.041
pH = 0.34
R2= 0.12
pV = 4×10-3
pH = 0.51
R2= 0.13
p = 4×10-3
R2= 0.11
pV = 0.012
pH = 0.74
R2= 0.11
pV = 0.011
pH = 0.85
R2= 0.12
pV = 3×10-3
pH = 0.32
R2= 0.12
pV = 0.036
pH = 0.23
R2= 0.14
pV = 0.014
pH = 0.41
R2= 0.12
pV = 0.061
pH = 8×10-3
R2= 0.2
pV = 6×10-3
pH = 0.21
R2= 0.13
pV = 0.014
pH = 0.013
R2= 0.27
pV = 0.022
pH = 0.01
R2= 0.36
pV = 4×10-3
pH = 0.047
R2= 0.16
pV = 5×10-3
pH = 0.055
R2= 0.14
pV = 0.12
pH = 0.09
R2= 0.13
pV = 0.66
pH = 0.062
R2= 0.13
pV = 0.23
pH = 3×10-3
R2= 0.21
GDP
pV = 0.16
pH = 3×10-5
R2= 0.21
pV = 0.08
pH = 6×10-4
R2= 0.19
pV = 0.45
pH = 4×10-3
R2= 0.16
pV = 7×10-3
pH = 3×10-4
R2= 0.22
pV = 0.19
pH = 4×10-3
R2= 0.15
pV = 8×10-4
pH = 1×10-5
R2= 0.22
pV = 0.028
pH = 4×10-3
R2= 0.16
pV = 0.25
pH = 0.02
R2= 0.13
pV = 0.12
pH = 0.035
R2= 0.13
pV = 0.74
pH = 0.012
R2= 0.11
p = 1×10-3
R2= 0.087
pV = 4×10-3
pH = 0.03
R2= 0.14
pV = 7×10-3
pH = 0.037
R2= 0.12
pV = 0.31
pH = 4×10-3
R2= 0.16
pV = 0.54
pH = 2×10-3
R2= 0.16
pV = 0.045
pH = 0.01
R2= 0.14
pV = 0.23
pH = 0.028
R2= 0.12
pV = 0.24
pH = 3×10-3
R2= 0.17
pV = 0.55
pH = 2×10-3
R2= 0.21
pV = 1×10-3
pH = 0.022
R2= 0.13
pV = 9×10-5
pH = 9×10-3
R2= 0.19
pV = 0.081
pH = 0.026
R2= 0.082
pV = 0.23
pH = 6×10-4
R2= 0.2
pV = 0.05
pH = 2×10-3
R2= 0.18
ALCO
pV = 0.68
pH = 2×10-5
R2= 0.2
pV = 0.79
pH = 4×10-4
R2= 0.17
pV = 0.066
pH = 2×10-4
R2= 0.18
pV = 0.088
pH = 4×10-5
R2= 0.19
pV = 0.017
pH = 3×10-5
R2= 0.2
pV = 0.048
pH = 9×10-4
R2= 0.17
pV = 0.36
pH = 7×10-3
R2= 0.13
pV = 0.047
pH = 3×10-3
R2= 0.14
pV = 0.011
pH = 6×10-4
R2= 0.16
pV = 0.85
pH = 0.011
R2= 0.12
pV = 0.03
pH = 4×10-3
R2= 0.14
p = 2×10-3
R2= 0.074
pV = 0.036
pH = 0.069
R2= 0.099
pV = 0.14
pH = 3×10-4
R2= 0.17
pV = 0.098
pH = 4×10-4
R2= 0.16
pV = 0.052
pH = 0.017
R2= 0.12
pV = 0.04
pH = 6×10-4
R2= 0.16
pV = 0.26
pH = 9×10-3
R2= 0.14
pV = 0.62
pH = 8×10-3
R2= 0.17
pV = 3×10-3
pH = 0.018
R2= 0.12
pV = 2×10-3
pH = 0.016
R2= 0.14
pV = 0.23
pH = 0.047
R2= 0.064
pV = 0.95
pH = 5×10-4
R2= 0.17
pV = 0.37
pH = 3×10-3
R2= 0.14
SMOK
pV = 0.81
pH = 1×10-5
R2= 0.2
pV = 0.72
pH = 2×10-4
R2= 0.17
pV = 0.37
pH = 4×10-4
R2= 0.16
pV = 0.049
pH = 8×10-5
R2= 0.2
pV = 0.076
pH = 4×10-4
R2= 0.16
pV = 0.058
pH = 2×10-4
R2= 0.16
pV = 0.95
pH = 7×10-3
R2= 0.13
pV = 0.17
pH = 3×10-3
R2= 0.13
pV = 0.054
pH = 1×10-3
R2= 0.14
pV = 0.32
pH = 3×10-3
R2= 0.12
pV = 0.037
pH = 7×10-3
R2= 0.12
pV = 0.069
pH = 0.036
R2= 0.099
p = 4×10-3
R2= 0.065
pV = 0.54
pH = 5×10-4
R2= 0.16
pV = 0.22
pH = 9×10-4
R2= 0.14
pV = 0.11
pH = 5×10-3
R2= 0.13
pV = 0.029
pH = 1×10-3
R2= 0.15
pV = 0.67
pH = 0.013
R2= 0.15
pV = 0.59
pH = 3×10-3
R2= 0.21
pV = 6×10-3
pH = 0.023
R2= 0.1
pV = 2×10-3
pH = 0.011
R2= 0.14
pV = 0.019
pH = 0.013
R2= 0.11
pV = 0.63
pH = 1×10-4
R2= 0.19
pV = 0.055
pH = 3×10-4
R2= 0.18
ANE
pV = 0.063
pH = 1×10-3
R2= 0.22
pV = 0.043
pH = 0.019
R2= 0.19
pV = 0.27
pH = 0.29
R2= 0.16
pV = 4×10-4
pH = 1×10-3
R2= 0.26
pV = 0.015
pH = 9×10-3
R2= 0.2
pV = 5×10-4
pH = 1×10-3
R2= 0.22
pV = 8×10-3
pH = 0.08
R2= 0.18
pV = 7×10-3
pH = 0.32
R2= 0.16
pV = 6×10-3
pH = 0.19
R2= 0.17
pV = 0.23
pH = 0.036
R2= 0.14
pV = 4×10-3
pH = 0.31
R2= 0.16
pV = 3×10-4
pH = 0.14
R2= 0.17
pV = 5×10-4
pH = 0.54
R2= 0.16
p = 6×10-6
R2= 0.15
pV = 0.11
pH = 0.19
R2= 0.16
pV = 3×10-3
pH = 0.91
R2= 0.15
pV = 0.031
pH = 0.32
R2= 0.16
pV = 8×10-3
pH = 2×10-3
R2= 0.24
pV = 6×10-3
pH = 9×10-4
R2= 0.32
pV = 2×10-5
pH = 0.036
R2= 0.18
pV = 5×10-6
pH = 1×10-2
R2= 0.23
pV = 1×10-3
pH = 8×10-3
R2= 0.16
pV = 0.011
pH = 0.016
R2= 0.23
pV = 3×10-3
pH = 0.04
R2= 0.22
POLL
pV = 0.014
pH = 1×10-4
R2= 0.24
pV = 0.035
pH = 9×10-3
R2= 0.19
pV = 0.25
pH = 0.13
R2= 0.16
pV = 6×10-5
pH = 3×10-4
R2= 0.28
pV = 8×10-3
pH = 8×10-3
R2= 0.18
pV = 6×10-3
pH = 2×10-3
R2= 0.19
pV = 5×10-3
pH = 0.029
R2= 0.18
pV = 0.041
pH = 0.23
R2= 0.14
pV = 0.017
pH = 0.29
R2= 0.15
pV = 0.41
pH = 0.014
R2= 0.12
pV = 2×10-3
pH = 0.54
R2= 0.16
pV = 4×10-4
pH = 0.098
R2= 0.16
pV = 9×10-4
pH = 0.22
R2= 0.14
pV = 0.19
pH = 0.11
R2= 0.16
p = 3×10-5
R2= 0.13
pV = 0.018
pH = 0.21
R2= 0.15
pV = 0.035
pH = 0.32
R2= 0.14
pV = 0.078
pH = 2×10-3
R2= 0.2
pV = 0.044
pH = 5×10-4
R2= 0.29
pV = 2×10-5
pH = 0.011
R2= 0.18
pV = 6×10-6
pH = 6×10-3
R2= 0.23
pV = 3×10-4
pH = 5×10-3
R2= 0.18
pV = 0.056
pH = 3×10-3
R2= 0.22
pV = 0.025
pH = 0.024
R2= 0.19
HEP
pV = 0.09
pH = 5×10-5
R2= 0.22
pV = 0.42
pH = 9×10-4
R2= 0.17
pV = 0.91
pH = 3×10-3
R2= 0.15
pV = 6×10-3
pH = 4×10-5
R2= 0.22
pV = 2×10-3
pH = 2×10-4
R2= 0.2
pV = 0.061
pH = 4×10-3
R2= 0.16
pV = 0.086
pH = 6×10-3
R2= 0.15
pV = 0.11
pH = 0.05
R2= 0.13
pV = 0.15
pH = 0.023
R2= 0.13
pV = 8×10-3
pH = 0.061
R2= 0.2
pV = 0.01
pH = 0.045
R2= 0.14
pV = 0.017
pH = 0.052
R2= 0.12
pV = 5×10-3
pH = 0.11
R2= 0.13
pV = 0.91
pH = 3×10-3
R2= 0.15
pV = 0.21
pH = 0.018
R2= 0.15
p = 2×10-4
R2= 0.11
pV = 0.052
pH = 0.037
R2= 0.14
pV = 0.015
pH = 7×10-3
R2= 0.25
pV = 0.026
pH = 3×10-3
R2= 0.3
pV = 1×10-4
pH = 7×10-3
R2= 0.16
pV = 1×10-4
pH = 0.027
R2= 0.18
pV = 0.022
pH = 0.018
R2= 0.1
pV = 0.18
pH = 3×10-3
R2= 0.21
pV = 0.043
pH = 0.012
R2= 0.18
PRE
pV = 0.013
pH = 1×10-5
R2= 0.24
pV = 0.027
pH = 2×10-3
R2= 0.2
pV = 0.32
pH = 0.033
R2= 0.16
pV = 5×10-3
pH = 6×10-4
R2= 0.23
pV = 0.077
pH = 9×10-3
R2= 0.16
pV = 8×10-4
pH = 9×10-5
R2= 0.22
pV = 2×10-3
pH = 2×10-3
R2= 0.19
pV = 0.042
pH = 0.029
R2= 0.14
pV = 0.065
pH = 0.29
R2= 0.14
pV = 0.21
pH = 6×10-3
R2= 0.13
pV = 0.028
pH = 0.23
R2= 0.12
pV = 6×10-4
pH = 0.04
R2= 0.16
pV = 1×10-3
pH = 0.029
R2= 0.15
pV = 0.32
pH = 0.031
R2= 0.16
pV = 0.32
pH = 0.035
R2= 0.14
pV = 0.037
pH = 0.052
R2= 0.14
p = 2×10-4
R2= 0.11
pV = 0.12
pH = 2×10-3
R2= 0.19
pV = 0.058
pH = 5×10-4
R2= 0.28
pV = 5×10-4
pH = 0.057
R2= 0.14
pV = 2×10-4
pH = 0.018
R2= 0.17
pV = 5×10-3
pH = 0.016
R2= 0.13
pV = 0.028
pH = 5×10-5
R2= 0.23
pV = 0.2
pH = 4×10-3
R2= 0.16
D
pV = 6×10-3
pH = 3×10-3
R2= 0.3
pV = 1×10-2
pH = 0.26
R2= 0.14
pV = 7×10-3
pH = 0.15
R2= 0.16
pV = 0.011
pH = 0.056
R2= 0.18
pV = 6×10-3
pH = 0.7
R2= 0.15
pV = 0.02
pH = 4×10-3
R2= 0.29
pV = 0.015
pH = 0.47
R2= 0.13
pV = 5×10-3
pH = 0.04
R2= 0.22
pV = 0.01
pH = 0.13
R2= 0.16
pV = 0.013
pH = 0.014
R2= 0.27
pV = 3×10-3
pH = 0.24
R2= 0.17
pV = 9×10-3
pH = 0.26
R2= 0.14
pV = 0.013
pH = 0.67
R2= 0.15
pV = 2×10-3
pH = 8×10-3
R2= 0.24
pV = 2×10-3
pH = 0.078
R2= 0.2
pV = 7×10-3
pH = 0.015
R2= 0.25
pV = 2×10-3
pH = 0.12
R2= 0.19
p = 6×10-3
R2= 0.15
pV = 0.69
pH = 0.27
R2= 0.26
pV = 6×10-3
pH = 0.34
R2= 0.16
pV = 0.068
pH = 0.57
R2= 0.096
pV = 0.04
pH = 0.36
R2= 0.18
pV = 4×10-3
pH = 0.02
R2= 0.25
pV = 2×10-3
pH = 9×10-4
R2= 0.34
Ds
pV = 0.014
pH = 0.018
R2= 0.32
pV = 9×10-3
pH = 0.75
R2= 0.17
pV = 4×10-3
pH = 0.14
R2= 0.21
pV = 8×10-3
pH = 0.24
R2= 0.2
pV = 3×10-3
pH = 0.97
R2= 0.21
pV = 5×10-3
pH = 1×10-3
R2= 0.4
pV = 1×10-2
pH = 0.9
R2= 0.17
pV = 2×10-3
pH = 0.047
R2= 0.28
pV = 3×10-3
pH = 0.046
R2= 0.25
pV = 0.01
pH = 0.022
R2= 0.36
pV = 2×10-3
pH = 0.55
R2= 0.21
pV = 8×10-3
pH = 0.62
R2= 0.17
pV = 3×10-3
pH = 0.59
R2= 0.21
pV = 9×10-4
pH = 6×10-3
R2= 0.32
pV = 5×10-4
pH = 0.044
R2= 0.29
pV = 3×10-3
pH = 0.026
R2= 0.3
pV = 5×10-4
pH = 0.058
R2= 0.28
pV = 0.27
pH = 0.69
R2= 0.26
p = 2×10-3
R2= 0.21
pV = 3×10-3
pH = 0.48
R2= 0.22
pV = 0.029
pH = 0.64
R2= 0.15
pV = 0.042
pH = 0.31
R2= 0.2
pV = 2×10-3
pH = 7×10-3
R2= 0.34
pV = 5×10-4
pH = 2×10-4
R2= 0.44
CO2
pV = 0.084
pH = 1×10-6
R2= 0.22
pV = 0.017
pH = 4×10-6
R2= 0.2
pV = 0.022
pH = 1×10-5
R2= 0.19
pV = 0.97
pH = 2×10-4
R2= 0.17
pV = 0.81
pH = 6×10-4
R2= 0.14
pV = 2×10-3
pH = 4×10-6
R2= 0.2
pV = 0.034
pH = 1×10-4
R2= 0.16
pV = 0.01
pH = 7×10-5
R2= 0.16
pV = 0.014
pH = 1×10-4
R2= 0.16
pV = 0.047
pH = 4×10-3
R2= 0.16
pV = 0.022
pH = 1×10-3
R2= 0.13
pV = 0.018
pH = 3×10-3
R2= 0.12
pV = 0.023
pH = 6×10-3
R2= 0.1
pV = 0.036
pH = 2×10-5
R2= 0.18
pV = 0.011
pH = 2×10-5
R2= 0.18
pV = 7×10-3
pH = 1×10-4
R2= 0.16
pV = 0.057
pH = 5×10-4
R2= 0.14
pV = 0.34
pH = 6×10-3
R2= 0.16
pV = 0.48
pH = 3×10-3
R2= 0.22
p = 0.016
R2= 0.047
pV = 0.11
pH = 0.17
R2= 0.076
pV = 1×10-3
pH = 0.014
R2= 0.15
pV = 0.011
pH = 3×10-6
R2= 0.25
pV = 0.021
pH = 8×10-5
R2= 0.19
DIAB
pV = 0.012
pH = 2×10-5
R2= 0.21
pV = 8×10-3
pH = 2×10-6
R2= 0.25
pV = 0.017
pH = 6×10-6
R2= 0.23
pV = 0.33
pH = 1×10-5
R2= 0.24
pV = 0.11
pH = 5×10-3
R2= 0.12
pV = 8×10-3
pH = 7×10-7
R2= 0.26
pV = 9×10-3
pH = 5×10-5
R2= 0.2
pV = 4×10-3
pH = 8×10-6
R2= 0.22
pV = 0.011
pH = 5×10-4
R2= 0.16
pV = 0.055
pH = 5×10-3
R2= 0.14
pV = 9×10-3
pH = 9×10-5
R2= 0.19
pV = 0.016
pH = 2×10-3
R2= 0.14
pV = 0.011
pH = 2×10-3
R2= 0.14
pV = 1×10-2
pH = 5×10-6
R2= 0.23
pV = 6×10-3
pH = 6×10-6
R2= 0.23
pV = 0.027
pH = 1×10-4
R2= 0.18
pV = 0.018
pH = 2×10-4
R2= 0.17
pV = 0.57
pH = 0.068
R2= 0.096
pV = 0.64
pH = 0.029
R2= 0.15
pV = 0.17
pH = 0.11
R2= 0.076
p = 0.02
R2= 0.052
pV = 0.028
pH = 8×10-3
R2= 0.14
pV = 0.081
pH = 4×10-6
R2= 0.28
pV = 5×10-3
pH = 4×10-7
R2= 0.33
BCG
pV = 0.02
pH = 2×10-4
R2= 0.19
pV = 0.063
pH = 0.031
R2= 0.097
pV = 4×10-3
pH = 6×10-4
R2= 0.16
pV = 0.034
pH = 8×10-4
R2= 0.18
pV = 7×10-3
pH = 3×10-4
R2= 0.18
pV = 0.016
pH = 3×10-4
R2= 0.19
pV = 0.011
pH = 4×10-3
R2= 0.14
pV = 7×10-3
pH = 7×10-4
R2= 0.16
pV = 0.014
pH = 2×10-3
R2= 0.14
pV = 0.09
pH = 0.12
R2= 0.13
pV = 0.026
pH = 0.081
R2= 0.082
pV = 0.047
pH = 0.23
R2= 0.064
pV = 0.013
pH = 0.019
R2= 0.11
pV = 8×10-3
pH = 1×10-3
R2= 0.16
pV = 5×10-3
pH = 3×10-4
R2= 0.18
pV = 0.018
pH = 0.022
R2= 0.1
pV = 0.016
pH = 5×10-3
R2= 0.13
pV = 0.36
pH = 0.04
R2= 0.18
pV = 0.31
pH = 0.042
R2= 0.2
pV = 0.014
pH = 1×10-3
R2= 0.15
pV = 8×10-3
pH = 0.028
R2= 0.14
p = 0.031
R2= 0.05
pV = 0.17
pH = 5×10-3
R2= 0.16
pV = 0.17
pH = 0.023
R2= 0.12
RH+ pV = 0.069pH = 0.012
R2= 0.25
pV = 1×10-2
pH = 0.3
R2= 0.18
pV = 4×10-3
pH = 0.048
R2= 0.21
pV = 8×10-4
pH = 2×10-3
R2= 0.24
pV = 1×10-5
pH = 3×10-3
R2= 0.27
pV = 4×10-3
pH = 0.075
R2= 0.21
pV = 2×10-3
pH = 0.63
R2= 0.18
pV = 8×10-3
pH = 0.55
R2= 0.19
pV = 1×10-3
pH = 0.046
R2= 0.21
pV = 0.062
pH = 0.66
R2= 0.13
pV = 6×10-4
pH = 0.23
R2= 0.2
pV = 5×10-4
pH = 0.95
R2= 0.17
pV = 1×10-4
pH = 0.63
R2= 0.19
pV = 0.016
pH = 0.011
R2= 0.23
pV = 3×10-3
pH = 0.056
R2= 0.22
pV = 3×10-3
pH = 0.18
R2= 0.21
pV = 5×10-5
pH = 0.028
R2= 0.23
pV = 0.02
pH = 4×10-3
R2= 0.25
pV = 7×10-3
pH = 2×10-3
R2= 0.34
pV = 3×10-6
pH = 0.011
R2= 0.25
pV = 4×10-6
pH = 0.081
R2= 0.28
pV = 5×10-3
pH = 0.17
R2= 0.16
p = 2×10-5
R2= 0.19
pV = 5×10-3
pH = 0.088
R2= 0.22
B+ pV = 0.012pH = 2×10-4
R2= 0.27
pV = 0.014
pH = 0.029
R2= 0.18
pV = 0.013
pH = 0.015
R2= 0.19
pV = 1×10-3
pH = 1×10-3
R2= 0.23
pV = 2×10-5
pH = 4×10-4
R2= 0.25
pV = 0.028
pH = 0.085
R2= 0.18
pV = 1×10-3
pH = 0.026
R2= 0.18
pV = 0.043
pH = 0.12
R2= 0.17
pV = 0.022
pH = 0.08
R2= 0.16
pV = 3×10-3
pH = 0.23
R2= 0.21
pV = 2×10-3
pH = 0.05
R2= 0.18
pV = 3×10-3
pH = 0.37
R2= 0.14
pV = 3×10-4
pH = 0.055
R2= 0.18
pV = 0.04
pH = 3×10-3
R2= 0.22
pV = 0.024
pH = 0.025
R2= 0.19
pV = 0.012
pH = 0.043
R2= 0.18
pV = 4×10-3
pH = 0.2
R2= 0.16
pV = 9×10-4
pH = 2×10-3
R2= 0.34
pV = 2×10-4
pH = 5×10-4
R2= 0.44
pV = 8×10-5
pH = 0.021
R2= 0.19
pV = 4×10-7
pH = 5×10-3
R2= 0.33
pV = 0.023
pH = 0.17
R2= 0.12
pV = 0.088
pH = 5×10-3
R2= 0.22
p = 2×10-4
R2= 0.14
Figure 31: Significance and R2 for two-variable linear fits of α, with each variable chosen in pairs in each
entry. Variables names are the same as in legend of Fig. 30. Each cell in the table gives R2 and the p-value
of the each of the two variables, using t-statistic, labeled as pH for horizontal and pV for vertical.
A. Possible Interpretations
The set of most significant variables, i.e. with smallest p-value, which correlate with faster prop-
agation of COVID-19 are the following: low temperature, high percentage of old vs working people
and life expectancy, number of international tourist arrivals, high percentage of RH- blood types,
earlier starting date of the epidemic, high physical contact in greeting habits, prevalence of lung
cancer. Such variables are however correlated with each other and we analyze them together below.
Most other variables are mildly/strongly correlated with the previous set of variables, except for:
prevalence of Type-I diabetes, BCG vaccination, Vitamin D levels, which might indeed be considered
as almost independent factors.
From the above table one can verify that all the “counterintuitive” variables (death-rate due to
pollution, POLL, prevalence of anemia, ANE, prevalence of hepatitis B, HEP, high blood pressure
in women, PRE) have a strong negative correlation with life expectancy, LIFE. This offers a neat
possible interpretation: since countries with high deaths by pollution or high prevalence of anemia
or hepatitis B or high blood pressure in women have a younger population, then the virus spread
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is slower. Therefore one expects that when performing a fit with any of such variable and LIFE
together, one of the variables will turn out to be non-significant, i.e. redundant. Indeed one may
verify from Table 31 that this happens for all of the four above variables.
Redundancy is also present when one of the following variables is used together with life expectancy
in a 2 variables fit: smoking, urbanization, obesity in males. Also, old age dependency and life
expectancy are obviously quite highly correlated.
Other variables instead do not have such an interpretation: BCG vaccination, type-1 diabetes in
children and vitamin D levels. In this case other interpretations have to be looked for. Regarding
the vaccination a promising interpretation is indeed that BCG-vaccinated people could be more
protected against COVID-19 [29–31].
Lung cancer and alcohol consumption remain rather significant, close to a p-value of 0.05, even
after taking into account for life expectancy, but they become non-significant when combining with
old age dependency. In this case it is also difficult to disentangle them from the fact that old people
are more subject to COVID-19 infection.
Blood type RH+ is also quite correlated with T (and with old age dependency ratio), however it
remains moderately significant when combined with it.
Finally vitamin D levels, which are measured on a smaller sample, also have little correlations
with the main factors and might indeed constitute an independent factor. This factor is also quite
interesting, since it may open avenues for research on protective factors. It is quite possible that
high levels of Vitamin D have an impact on the immune response to COVID-19 [45–47].
B. Multiple variable fits
It is not too difficult to identify redundant variables, looking at very strongly correlated pairs in
Table 30. It is generically harder, instead, to extract useful information when combining more than
2 or 3 variables, since we have many variables with a comparable predictive power (individual R2
are at most around 0.2) and several of them exhibit mild/strong correlations. In the following we
perform examples of fits with some of the most predictive variables, trying to keep small correlation
between them.
1. Temperature+Arrivals+Greetings
Here we show an example of a fit with 3 parameters.
Estimate Standard Error t-Statistic p-value
1 0.149 0.0247 6.02 2.67× 10−8
T -0.00247 0.000709 -3.48 0.000741
ARR 1.72× 10−9 4.24× 10−10 4.05 0.0000976
GRE 0.0972 0.0276 3.52 0.000651
R2 0.36
N 107

1. −0.65 −0.37 −0.83
−0.65 1. 0.28 0.24
−0.37 0.28 1. 0.1
−0.83 0.24 0.1 1.

Table XXX: In the left upper panel: best-estimate, standard error (σ), t-statistic and p-value for the param-
eters of the linear interpolation. In the right panels: R2 for the best-estimate and number of countries N .
Below we show the correlation matrix for all variables.
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2. Temperature+Arrivals+Greetings+Starting date
Here we show an example of a fit with 4 parameters. As we combine more than 3 parameters,
typically at least one of them becomes less significant.
Estimate Standard Error t-Statistic p-value
1 0.299 0.0519 5.77 8.66× 10−8
T -0.00169 0.000718 -2.36 0.0203
ARR 7.69× 10−10 4.99× 10−10 1.54 0.126
GRE 0.13 0.0283 4.59 0.0000127
DATE -0.00237 0.000728 -3.26 0.00154
R2 0.42
N 107

1. 0.016 −0.66 −0.04 −0.89
0.016 1. 0.025 0.33 −0.33
−0.66 0.025 1. −0.13 0.58
−0.04 0.33 −0.13 1. −0.35
−0.89 −0.33 0.58 −0.35 1.

Table XXXI: In the left upper panel: best-estimate, standard error (σ), t-statistic and p-value for the
parameters of the linear interpolation. In the right panels: R2 for the best-estimate and number of countries
N . Below we show the correlation matrix for all variables.
3. Many variables fit
One may think of combining all our variables. This is however not a straightforward task, because
we do not have data on the same number N of countries for all variables. As a compromise we
may restrict to a large number of variables, but still keeping a large number of countries. For
instance we may choose the following set: T, OLD, LIFE, ARR, DATE, GRE, LUNG, OBE, URB,
GDP, ALCO, SMOK, ANE, POLL, HEP, PRE, CO2. These variables are defined for a sample of
N = 102 countries. By combining all of them we get R2 = 0.48, which tells us that only about
half of the variance is described by these variables. Moreover clearly many of these variables are
redundant. Indeed by diagonalizing the covariance matrix one finds that only about 7 independent
linear combinations of the factors are significant.
Rather than reporting such factors, which is not particuarly illuminating, we checked that for
instance eliminating the following factors reduces the R2 very little, to about R2 ≈ 0.47: ALCO,
SMOK, ANE, POLL, CO2, OBE. Moreover, reducing just to 6 variables, e.g. T, LIFE, ARR, DATE,
GRE, LUNG, brings R2 down to about 0.44. Such a choice however is not unique, due to redundancy
of our variables.
VI. CONCLUSIONS
We have collected data for countries that had at least 12 days of data after a starting point, which
we fixed to be at the threshold of 30 confirmed cases. We considered a dataset of 126 countries,
collected on April 15th. We have fit the data for each country with an exponential and extracted
the exponents α, for each country. Then we have correlated such exponents with several variables,
one by one.
We found a positive correlation with high confidence level with the following variables, with re-
spective p-value: low temperature (negative correlation, p-value 4 · 10−7), high ratio of old people
vs. people in the working-age (15-64 years) (p-value 3 · 10−6), life expectancy (p-value 8 · 10−6),
international tourism: number of arrivals (p-value 1 · 10−5), earlier start of the epidemic (p-value
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2 ·10−5), high amount of contact in greeting habits (positive correlation, p-value 5 ·10−5), lung cancer
death rates (p-value 6 · 10−5), obesity in males (p-value 1 · 10−4), share of population in urban areas
( p-value 2 ·10−4), share of population with cancer (p-value 2.8 ·10−4), alcohol consumption (p-value
0.0019), daily smoking prevalence (p-value 0.0036), low UV index (p-value 0.004; smaller sample, 73
countries), low vitamin D serum levels (annual values p-value 0.006, seasonal values 0.002; smaller
sample, ∼ 50 countries).
We find moderate evidence for positive correlation with: CO2 (and SO) emissions (p-value 0.015),
type-1 diabetes in children (p-value 0.023), vaccination coverage for Tuberculosis (BCG) (p-value
0.028).
Counterintuitively we also find negative correlations, in a direction opposite to a naive expectation,
with: death rate from air pollution (p-value 3 · 10−5), prevalence of anemia, adults and children, (p-
value 1 · 10−4 and 7 · 10−6, respectively), share of women with high-blood-pressure (p-value 2 · 10−4),
incidence of Hepatitis B (p-value 2 · 10−4), PM2.5 air pollution (p-value 0.029).
As is clear from the figures, the data present a high amount of dispersion, for all fits that we
have performed. This is of course unavoidable, given the existence of many systematic effects. One
obvious factor is that the data are collected at country level, whereas many of the factors considered
are regional. This is obvious from empirical data (see for instance the difference between the epidemic
development in Lombardy vs. other regions in Italy, or New York vs. more rural regions), and also
sometimes has obvious explanations (climate, health factors vary a lot region by region) as well as
not so obvious ones. Because of this, we consider R2 values as at least as important as p-values and
correlation coefficients: an increase of the R2 after a parameter is included means that the parameter
has a systematic effect in reducing the dispersion (“more data points are explained”).
Several of the above variables are correlated with each other and so they are likely to have a
common interpretation and it is not easy to disentangle them. The correlation structure is quite rich
and non-trivial, and we encourage interested readers to study the tables in detail, giving both R2,
p-values and correlation estimates. Note that some correlations are “obvious”, for example between
temperature and UV radiation. Others are accidental, historical and sociological. For instance, social
habits like alcohol consumption and smoking are correlated with climatic variables. In a similar vein
correlation of smoking and lung cancer is very high, and this is likely to contribute to the correlation
of the latter with climate. Historical reasons also correlate climate with GDP per capita.
Other variables are found to have a counterintuitive negative correlation, which can be explained
due their strong negative correlation with life expectancy: death-rate due to pollution, prevalence of
anemia, Hepatitis B and high blood pressure for women.
We also analyzed the possible existence of a bias: countries with low GDP-per capita, typically
located in warm regions, might have less intense testing and we discussed the correlation with the
above variables, showing that most of them remain significant, even after taking GDP into account.
In this respect, note that in countries where testing is not prevalent, registration of the illness is
dependent on the development of severe symptoms. Hence, while this study is about infection
rates rather than mortality, in quite a few countries we are actually measuring a proxy of mortality
rather than infection rate. Hence, effects affecting mortality will be more relevant. Pre-existing lung
conditions, diabetes, smoking and health indicators in general as well as pollution are likely to be
important in this respect, perhaps not affecting α per se but the detected amount of α. These are in
turn generally correlated with GDP and temperature for historical reasons. Other interpretations,
which may be complementary, are that co-morbidities and old age affect immune response and thus
may directly increase the growth rate of the contagion. Similarly it is likely that individuals with
co-morbidities and old age, developing a more severe form of the disease, are also more contagious
than younger or asymptomatic individuals, producing thus an increase in α. In this regard, we wish
to point the reader’s attention to the relevant differences in correlations once we apply a threshold on
GDP per capita. It has long been known that human wellness (we refer to a psychological happiness
study [53], but the point is more general) depends non-linearly on material resources, being strongly
correlated when resources are low and reaching a plateau after a critical limit. The biases described
above (weather comorbidity, testing facilities, pre-existing conditions and environmental factors)
seem to reflect this, changing considerably in the case our sample has a threshold w.r.t. a more
general analysis without a threshold.
About pollution our findings are mixed. We find no correlation with generic air pollution (“Sus-
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pended particulate matter (SPM), in micrograms per cubic metre”). We find higher contagion to
be moderately correlated only with and CO2/SO emissions. Instead we find a negative correlation
with death rates due to air pollution and PM2.5 concentration (in contrast with [48]). Note however
that correlation with PM2.5 becomes non significant when combined with GDP per capita, while
CO2/SO becomes non significant when combined with tourist arrivals. Finally death rates due to
air pollution is also redundant when correlating with life expectancy.
Some of the variables that we have studied cannot be arbitrarily changed, but can be taken into
account by public health policies, such as temperature, amount of old people and life expectancy, by
implementing stronger testing and tracking policies, and possibly lockdowns, both with the arrival
of the cold seasons and for the old aged population.
Other variables instead can be controlled by governments: testing and isolating international
travelers and reducing number of flights in more affected regions; promoting social distancing habits
as long as the virus is spreading, such as campaigns for reducing physical contact in greeting habits;
campaigns to increase the intake of vitamin D, decrease smoking and obesity.
We also emphasize that some variables are useful to inspire and support medical research, such
as correlation of contagion with: lung cancer, obesity, low vitamin D levels, blood types (higher risk
for all RH- types, A types, lower risk for B+ type), type 1 diabetes. This definitely deserves further
study, also of correlational type using data from patients.
In conclusion, our findings can thus be very useful both for policy makers and for further experi-
mental research.
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Appendix A: Vitamin D
We collected most data on vitamin D from [35–39] and from references therein. For a first dataset
of 50 countries we have collected annual averages. For many countries several studies with different
values were found and in this case we have collected the mean and the standard error (when available)
and a weighted average has been performed. The resulting values that we have used are listed in
Table XXXII.
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Country Vit D (annual) Vit D (seasonal)
Argentina 53 55.8
Australia 66 62.1
Austria 13.5 N/A
Belgium 51.7 49.3
Brazil 67.6 65.
Canada 67.7 64.
Chile 42.3 41.2
China 45 31.7
Croatia 46.6 40.1
Czech Republic 62.4 N/A
Denmark 60.6 54.4
Estonia 49.8 44.7
Finland 58.2 46.6
France 58 50.9
Germany 51.4 49.9
Greece 67.9 62.2
Hungary 61.6 51.
Iceland 57 N/A
India 42 42.
Iran 36.6 40.
Ireland 56.4 N/A
Israel 56.5 56.5
Italy 46.4 37.2
Japan 67.3 59.9
Lebanon 28.5 N/A
Country Vit D (annual) Vit D (seasonal)
Lithuania 53.3 48.5
Mexico 58.5 59.
Morocco 39.5 N/A
Netherlands 56 49.8
New Zealand 58.1 66.2
Norway 64.27 56.5
Poland 53.5 41.9
Romania 40.2 34.4
Russia 29.2 N/A
Arabia Saudi 35.7 28.5
Singapore 56 56.
Slovakia 81.5 N/A
South Africa 47 59.1
South Korea 49 38.5
Spain 51.9 43.2
Sweden 73 69.
Switzerland 50 41.
Taiwan 74 71.2
Thailand 64.7 64.7
Tunisia 38.8 N/A
Turkey 43 N/A
Ukraine 35.8 32.5
UK 50.1 37.
USA 83.4 80.5
Vietnam 79.6 79.6
Table XXXII: Vitamin D serum levels (in nmol/l) obtained with a weighted average from refs. [35–39] and
references therein. The “annual” level refers to an average over the year. The “seasonal” level refers to the
value present in the literature, which is closer to the months of January-March: either the amount during
such months or during winter for northern hemisphere, or during summer for southern hemisphere or the
annual level for countries with little seasonal variation.
[1] Alessio Notari; medRxiv 2020.03.26.20044529; arXiv:2003.12417v4 [q-bio.PE]; doi:
https://doi.org/10.1101/2020.03.26.20044529.
[2] T. Fiolet, “Ecological Study on COVID-19: associations between the early growth rate and historical
environmental and socio-economic factors in 96 countries using GAM (Generalized Additive models);
Zenodo, doi = 10.5281/zenodo.3784948, url = https://doi.org/10.5281/zenodo.3784948;
[3] Demongeot, J.; Flet-Berliac, Y.; Seligmann, H. Temperature Decreases Spread Parameters of the New
COVID-19 Case Dynamics. Biology 2020, 9, 94.
[4] Wang, Mao; Jiang, Aili; Gong, Lijuan; Luo, Lina; Guo, Wenbin; Li, Chuyi; Li, Chaoyong; Yang, Bixing;
Zeng, Jietong; Chen, Youping; Zheng, Ke; Li, Hongyan. (2020). Temperature significant change COVID-
19 Transmission in 429 cities. https://www.medrxiv.org/content/10.1101/2020.02.22.20025791v1. doi:
10.1101/2020.02.22.20025791.
[5] Luo, Wei and Majumder, Maimuna S and Liu, Dianbo and Poirier, Canelle and Mandl, Kenneth D and
Lipsitch, Marc and Santillana, Mauricio, “The role of absolute humidity on transmission rates of the
COVID-19 outbreak”. https://www.medrxiv.org/content/early/2020/02/17/2020.02.12.20022467; doi =
10.1101/2020.02.12.20022467.
[6] Araujo, Miguel B. and Naimi, Babak, “Spread of SARS-CoV-2 Coronavirus likely to be con-
strained by climate”. https://www.medrxiv.org/content/early/2020/03/16/2020.03.12.20034728; doi =
41
10.1101/2020.03.12.20034728.
[7] Bukhari, Qasim and Jameel, Yusuf, “Will Coronavirus Pandemic Diminish by Summer?" ; Available at
SSRN: https://ssrn.com/abstract=3556998; doi = http://dx.doi.org/10.2139/ssrn.3556998.
[8] Jingyuan Wang, Ke Tang, Kai Feng, Weifeng Lv, “High Temperature and High Hu-
midity Reduce the Transmission of COVID-19". 2020. arXiv:2003.05003 [q-bio.PE], doi =
http://dx.doi.org/10.2139/ssrn.3556998.
[9] Sajadi, Mohammad M. and Habibzadeh, Parham and Vintzileos, Augustin and Shokouhi, Shervin
and Miralles-Wilhelm, Fernando and Amoroso, Anthony, “Temperature, Humidity and Lati-
tude Analysis to Predict Potential Spread and Seasonality for COVID-19"; Available at SSRN:
https://ssrn.com/abstract=3550308 or http://dx.doi.org/10.2139/ssrn.3550308.
[10] Marco Tulio Pacheco Coelho, Joao Fabricio Mota Rodrigues, Anderson Matos Medina, Paulo Scalco,
Levi Carina Terribile, Bruno Vilela, Jose Alexandre Felizola Diniz-Filho, Ricardo Dobrovolski; medRxiv
2020.04.02.20050773; doi: https://doi.org/10.1101/2020.04.02.20050773.
[11] In practice we choose, as the first day, the one in which the number of cases Ni is closest to 30. In some
countries, such a number Ni is repeated for several days; in such cases we choose the last of such days
as the starting point. For the particular case of China, we started from January 16th, with 59 cases,
since the number before that day was essentially frozen.
[12] https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases
[13] Taken from https://ourworldindata.org/charts
[14] Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three
hospitals within Wuhan, China Zhang, L. et al. Annals of Oncology, Volume 0, Issue 0. DOI:
https://doi.org/10.1016/j.annonc.2020.03.296.
[15] Kassir, R. Risk of COVID?19 for patients with obesity. Obesity Reviews. 2020; 21:e13034.
https://doi.org/10.1111/obr.13034.
[16] https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-
detail/q-a-on-smoking-and-COVID-19
[17] “A nicotinic hypothesis for COVID-19 with preventive and therapeutic implications” Jean-
Pierre Changeux, Zahir Amoura, Felix Rey, Makoto Miyara. Qeios ID: FXGQSB.2.
https://doi.org/10.32388/FXGQSB.2
[18] “Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19"; Makoto
Miyara, Florence Tubach, Valerie Pourcher, Capucine Morelot-Panzini, Julie Pernet, Julien Haroche,
Said Lebbah, Elise Morawiec, Guy Gorochov, Eric Caumes, Pierre Hausfater, Alain COMBES, Thomas
Similowski, Zahir Amoura. Qeios ID: WPP19W.3. https://doi.org/10.32388/WPP19W.3
[19] “A Novel Methodology for Epidemic Risk Assessment: the case of COVID-19 outbreak in Italy”, A.
Pluchino and A. E. Biondo and N. Giuffrida and G. Inturri and V. Latora and R. Le Moli and A.
Rapisarda and G. Russo and C. Zappala’, eprint 2004.02739, arXiv, physics.soc-ph.
[20] Stier, Andrew and Berman, Marc and Bettencourt, Luis, COVID-19 Attack Rate Increases with City
Size (March 30, 2020). Mansueto Institute for Urban Innovation Research Paper. Available at SSRN:
https://ssrn.com/abstract=3564464.
[21] UV radiation monitoring archive, http://www.temis.nl/uvradiation/UVarchive.html and WHO,
https://www.who.int/uv/intersunprogramme/activities/uv_index/en/index3.html
[22] V.Fioletov and B. Kerr, Canadian journal of public health. Revue canadienne de sante publique 101
(4) I5-9 (July 2010)
[23] https://diabetesatlas.org/data/en/indicators/12/
[24] Carlo Mengoli, Carlo Bonfanti, Chiara Rossi and Massimo Franchini Blood Transfus. 13(2): 313-317
(apr. 2015) doi: 10.2450/2014.0159-14 PMCID: PMC4385082 PMID: 25369594
[25] Amos Grunbaum, BabyMed https://www.babymed.com/pregnancy/
blood-type-and-rh-rhesus-status-countries
[26] Jiao Zhao et al, medRxiv 2020.03.11.20031096; doi: https://doi.org/10.1101/2020.03.11.20031096
[27] Swetaprovo Chaudhuri et al., arXiv:2004.10929
[28] https://guide.culturecrossing.net/basics_business_student_details.php and https://guide.
culturecrossing.net/
[29] Anita Shet et al., https://doi.org/10.1101/2020.04.01.20049478
[30] Paul Hegarty et al, https://doi.org/10.1101/2020.04.07.20053272doi
[31] “Correlation between universal BCG vaccination policy and reduced morbidity and mortality
for COVID-19: an epidemiological study”. Aaron Miller, Mac Josh Reandelar, Kimberly Fas-
ciglione, Violeta Roumenova, Yan Li, Gonzalo H Otazu medRxiv 2020.03.24.20042937; doi:
https://doi.org/10.1101/2020.03.24.20042937.
[32] https://clinicaltrials.gov/ct2/show/NCT04327206
[33] https://clinicaltrials.gov/ct2/show/NCT04328441
[34] https://clinicaltrials.gov/ct2/show/NCT04348370
42
[35] Vitamin D map developed by D.A. Wahl et al. on behalf of International Osteoporosis Foundation (IOF)
"A global representation of Vitamin D status in healthy populations". Archives of Osteoporosis 2012.
https://www.iofbonehealth.org/facts-and-statistics/vitamin-d-studies-map.
[36] Spiro, A. and Buttriss, J.L. (2014), Vitamin D status and intake in Europe. Nutrition Bulletin, 39:
322-350. doi:10.1111/nbu.12108
[37] Lips, P., Cashman, K., Lamberg-Allardt, C., Bischoff-Ferrari, H., Obermayer-Pietsch, B., Bianchi, M.,
Stepan, J., El-Hajj Fuleihan, G., Bouillon, R. (2019). Current vitamin D status in European and Middle
East countries and strategies to prevent vitamin D deficiency: a position statement of the European
Calcified Tissue Society, European Journal of Endocrinology, 180(4), P23-P54. Retrieved May 7, 2020,
from https://eje.bioscientifica.com/view/journals/eje/180/4/EJE-18-0736.xml
[38] Pludowski P, Grant WB, Bhattoa HP, et al. Vitamin d status in central europe. Int J Endocrinol.
2014;2014:589587. doi:10.1155/2014/589587.
[39] Kuchuk, N.O., van Schoor, N.M., Pluijm, S.M., Chines, A. and Lips, P. (2009), Vitamin D Status,
Parathyroid Function, Bone Turnover, and BMD in Postmenopausal Women With Osteoporosis: Global
Perspective. J Bone Miner Res, 24: 693-701. doi:10.1359/jbmr.081209
[40] Matthias Wacker and Michael Holick, Dermatoendocrinol. 5(1) 51-108 (2013)
[41] MH Edwards et.al., JARLIFE (The Journal of Aging Research and Lifestyle), http://www.jarlife.
net/703-the-global-epidemiology-of-vitamin-d-status.html
[42] N.Kuchuk et al, Journal of Bone and Mineral Research 24 4 693-701 (2009)
[43] Richard Semba et al, Eur J Clin Nutr. 64(2) 2010 203-209.
[44] Denys Wahl, Archives of Osteoporosis7(12):155-72 2012
[45] G.Isaia,E.Medico, Comunicato all’accademia di Medicina dell’Universita’ di Torino, https://www.
unitonews.it/storage/2515/8522/3585/Ipovitaminosi_D_e_Coronavirus_25_marzo_2020.pdf
[46] William B. Grant et al Nutrients 12(4), 988; https://doi.org/10.3390/nu12040988 (2020)
[47] Petre Cristian Ilie, Simina Stefanescu, Lee Smith et al. The role of Vitamin D in the prevention of
Coronavirus Disease 2019 infection and mortality, 08 April 2020, PREPRINT (Version 1) available at
Research Square [+https://doi.org/10.21203/rs.3.rs-21211/v1+].
[48] Exposure to air pollution and COVID-19 mortality in the United States. Xiao Wu, Rachel C. Neth-
ery, Benjamin M. Sabath, Danielle Braun, Francesca Dominici. medRxiv 2020.04.05.20054502; doi:
https://doi.org/10.1101/2020.04.05.20054502.
[49] Lei Fang, George Karakiulakis, Michael Roth. https://www.thelancet.com/pdfs/journals/lanres/PIIS2213-
2600(20)30116-8.pdf.
[50] https://en.wikipedia.org/wiki/Blood_type_distribution_by_country
[51] Kimball A, Hatfield KM, Arons M, James A, et al. MMWR, 69(13);377-381 (2020)
[52] Jou R, Huang WL, Su WJ. Tokyo-172 BCG vaccination complications, Taiwan. Emerg Infect Dis.
2009;15(9):1525?1526. doi:10.3201/eid1509.081336
[53] Andrew T. Jebb, Louis Tay, Ed Diener and Shigehiro Oishi Nature Human Behaviour 2(1):33-38 January
2018,10.1038/s41562-017-0277-0
[54] In practice we choose, as the first day, the one in which the number of cases Ni is closest to 30. In some
countries, such a number Ni is repeated for several days; in such cases we choose the last of such days
as the starting point. For the particular case of China, we started from January 16th, with 59 cases,
since the number before that day was essentially frozen.
[55] Countries were taken from [13], plus Taiwan added from [52].
